Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This company is toast.
Seems like KAYS isn't doing so well with processing edibles in their startup state ...KAYS LOSES BOTH LICENSES TO FARM AND PROCESS in Oregon! Well lookey here! Wouldn't ya know it the Kaya creeps have lost two licenses from playing crooked ball with the state and some unsuspecting investors.
https://www.oregon.gov/olcc/Docs/stipulated_settlements/marijuana/SSA_October2020_MJ.pdf
Sunstone Marketing Partners, LLC Robert Frey, Member/Manager dba KAYA FARMS (#A8DF) (Processor)
OAR 845-025-1160(4) – On or before August 18, 2018, Licensee or Licensee’s employees, agents, or representatives failed to notify the Commission of a change to its corporate or ownership structure, or in who has a financial interest in the business prior to making such a change when Bruce Burwick and/or MJAI Oregon 1, LLC obtained an ownership and/or financial interest in the licensed business without notification to or approval from the Commission prior to making the changes. Bruce Burwick obtained an ownership interest, as described in OAR 845-025- 1045(3), and/or a financial interest, as defined in OAR 845-025-1015(26), in the licensed business by becoming a 50% member of the licensed entity, Sunstone Management Partners, LLC, and/or providing it with approximately $3 million in capital investments. MJAI Oregon 1, LLC obtained an ownership interest, as described in OAR 845-025-1045(3), and/or financial interest, as defined in OAR 845-025-1015(26), in the licensed business by, including but not limited to: entering into a contract or contracts that allowed them to operate the licensed business, and subsequently operating the business, such that the performance of the business caused, or was capable of causing, them to benefit or suffer financially; and/or allowed them to exercise control over the business; incur debt or be entitled to incur debt or a similar obligation on behalf of the business; and/or enter into or be entitled to enter into a contract or a similar obligation on behalf of the business, other than as employees acting under the direction of the owner.
(Category I)
OAR 845-025-7520(1)(d) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed to properly tag all marijuana inventory with a unique identification (UID) tag pursuant to the system requirements of METRC Cannabis Tracking System when there were several jars of marijuana in a room on the licensed premises that did not have UID tags on them.
(1ST Level Category III)
OAR 845-025-1410(3)(b) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed during all hours when Licensee was not operating to keep all useable marijuana enclosed in an area that was secured with a steel door with a steel frame when several jars of marijuana were in a room with glass exterior doors.
SYNOPSIS: An investigation showed that Licensee Sunstone Partners had entered into an agreement with Kaya Farms whereby Kaya Farms was able to obtain ownership and financial interests in the licensed business without prior approval by the Commission. Pursuant to the agreement, Kaya Farms operated and exercised control over the licensed business and Licensee was no longer involved. A site inspection revealed additional Category III violations at both premises. Licensee agreed to surrender its license, and warranted that any sale of the business would not be to the entity that had obtained the unapproved interest in the business.
.
TERMS OF AGREEMENT
1. Licensee accepts responsibility for the violations as set out in the Notice. Violation Number One was Licensee’s first Category I violation. Violations Number Two and Three were Licensee’s first and second Category III violations within two years.
2. Commission staff proposed license cancellation for these violations. Licensee has begun the process of selling the business. Licensee will surrender its license on the date the transfer of ownership of the business is completed or at 12:00 PM on January 13, 2021, whichever is earlier.
3. Licensee understands and agrees that the Commission is not representing or guaranteeing that a new owner will have an approved license on or before January 13, 2021. Licensee understands and agrees that any new owner will have to fully complete the application process, and the application has to receive final approval by the Commission, prior to a license being issued.
4. Licensee agrees, represents, and warrants that the business will not be sold to the entity and/or individuals alleged to have obtained an unapproved financial and/or ownership interest in the licensed business, namely MJAI Oregon 1, LLC or Bruce Burwick, or to Kaya Holdings, Inc., the parent company of MJAI Oregon 1, LLC, or any parent, subsidiary, affiliate, or successor of Kaya Holdings, Inc.
5. Each licensee agrees to accept a letter of reprimand for the violations specified above. This letter of reprimand will become a permanent part of the licensee’s
Commission file and may be considered in any future application for any license or permit by the licensee.
6. Licensee hereby relinquishes any and all interest in any marijuana items in its inventory that have not been transferred before the effective date of license surrender, and agrees that the Commission may seize and destroy any such marijuana items.
7. Licensee withdraws its Request for Hearing in this matter.
8. In consideration of the forbearance stated herein, Licensee agrees to release and waive any and all claims of any kind, known or unknown, past or future, against the State of Oregon or its agencies, instrumentalities, employees, officers, or agents arising out of the matters set forth in the Third Amended Notice (including any prior versions of the Third Amended Notice) or this Settlement Agreement and the final order based hereon, including but not limited to any claim under federal or state law for damages, declaratory or equitable relief, under 42 USC §1983 et. seq., and for attorneys fees or costs.
9. The terms of this Settlement Agreement and the Final Order entered based on this Agreement are binding on Licensee and any of its agents, employees, representatives, successors or assigns.
10. This agreement is conditioned upon final approval of the Oregon Liquor Control Commission and will be reviewed by the Commissioners at their October 2020 Commission Meeting. If the agreement is not accepted and approved in its entirety by the Commission it is deemed null and void and Licensee’s hearing rights, if any, will be restored. If the agreement is accepted and approved in its entirety by the Commission, Licensee waives any and all rights to a contested case hearing under the Administrative Procedures Act (ORS Chapter 183) and to judicial review, or to otherwise challenge this agreement and the final order.
Sunstone Marketing Partners, LLC Robert Frey, Member/Manager dba KAYA FARMS (#035C) (Producer)
OAR 845-025-1160(4) – On or before August 29 18, 2018, Licensee or Licensee’s employees, agents, or representatives failed to notify the Commission of a change to its corporate or ownership structure, or in who has a financial interest in the business prior to making such a change when Bruce Burwick and/or MJAI Oregon 1, LLC obtained an ownership and/or financial interest in the licensed business without notification to or approval from the Commission prior to making the changes. Bruce Burwick obtained an ownership interest, as described in OAR 845-025- 1045(3), and/or a financial interest, as defined in OAR 845-025-1015(26), in the licensed business by becoming a 50% member of the licensed entity, Sunstone Management Partners, LLC, and/or providing it with approximately $3 million in capital investments. MJAI Oregon 1, LLC obtained an ownership interest, as described in OAR 845-025- 1045(3), and/or financial interest, as defined in OAR 845-025-1015(26), in the licensed business by, including but not limited to: entering into a contract or contracts that allowed them to operate the licensed business, and subsequently operating the business, such that the performance of the business caused, or was capable of causing, them to benefit or suffer financially; and/or allowed them to exercise control over the business; incur debt or be entitled to incur debt or a similar obligation on behalf of the business; and/or enter into or be entitled to enter into a contract or a similar obligation on behalf of the business, other than as employees acting under the direction of the owner.
(Category I)
OAR 845-025-7520(1)(c), (d) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed to properly tag all marijuana inventory and marijuana plants that were at least twenty four inches or identified as female with unique identification (UID) tags pursuant to the system requirements of METRC Cannabis Tracking System when there were bags of marijuana trim in a freezer, marijuana in two different drying rooms, and immature marijuana plants that were identified as female on the licensed premises that did not have UID tags on them.
(1st Level Category III
OAR 845-025-1410(3)(b) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed during all hours when Licensee was not operating to keep all useable marijuana enclosed in an area that was secured with a steel door with a steel frame when marijuana was stored in rooms that did not have steel doors and the exterior door leading into the licensed premises was not a steel door with a steel frame.
(1st Level Category III)
SYNOPSIS: An investigation showed that Licensee Sunstone Partners had entered into an agreement with Kaya Farms whereby Kaya Farms was able to obtain ownership and financial interests in the licensed business without prior approval by the Commission. Pursuant to the agreement, Kaya Farms operated and exercised control over the licensed business and Licensee was no longer involved. A site inspection revealed additional Category III violations at both premises. Licensee agreed to surrender its license, and warranted that any sale of the business would not be to the entity that had obtained the unapproved interest in the business.
TERMS OF AGREEMENT
1. Licensee accepts responsibility for the violations as set out in the Notice. Violation Number One was Licensee’s first Category I violation. Violations Number Two and Three were Licensee’s first and second Category III violations within two years.
2. Commission staff proposed license cancellation for these violations. Licensee has begun the process of selling the business. Licensee will surrender its license on the date the transfer of ownership of the business is completed or at 12:00 PM on January 13, 2021, whichever is earlier.
3. Licensee understands and agrees that the Commission is not representing or guaranteeing that a new owner will have an approved license on or before January 13, 2021. Licensee understands and agrees that any new owner will have to fully complete the application process, and the application has to receive final approval by the Commission, prior to a license being issued.
4. Licensee agrees, represents, and warrants that the business will not be sold to the entity and/or individuals alleged to have obtained an unapproved financial and/or ownership interest in the licensed business, namely MJAI Oregon 1, LLC or Bruce Burwick, or to Kaya Holdings, Inc., the parent company of MJAI Oregon 1, LLC, or any parent, subsidiary, affiliate, or successor of Kaya Holdings, Inc.
5. Each licensee agrees to accept a letter of reprimand for the violations specified above. This letter of reprimand will become a permanent part of the licensee’s Commission file and may be considered in any future application for any license or permit by the licensee.
6. Licensee hereby relinquishes any and all interest in any marijuana items in its inventory that have not been transferred before the effective date of
license surrender, and agrees that the Commission may seize and destroy any such marijuana items.
7. Licensee withdraws its Request for Hearing in this matter.
8. In consideration of the forbearance stated herein, Licensee agrees to release and waive any and all claims of any kind, known or unknown, past or future, against the State of Oregon or its agencies, instrumentalities, employees, officers, or agents arising out of the matters set forth in the Third Amended Notice (including any prior versions of the Third Amended Notice) or this Settlement Agreement and the final order based hereon, including but not limited to any claim under federal or state law for damages, declaratory or equitable relief, under 42 USC §1983 et. seq., and for attorneys fees or costs.
9. The terms of this Settlement Agreement and the Final Order entered based on this Agreement are binding on Licensee and any of its agents, employees, representatives, successors or assigns.
10. This agreement is conditioned upon final approval of the Oregon Liquor Control Commission and will be reviewed by the Commissioners at their October 2020 Commission Meeting. If the agreement is not accepted and approved in its entirety by the Commission it is deemed null and void and Licensee’s hearing rights, if any, will be restored. If the agreement is accepted and approved in its entirety by the Commission, Licensee waives any and all rights to a contested case hearing under the Administrative Procedures Act (ORS Chapter 183) and to judicial review, or to otherwise challenge this agreement and the final order.
Future Scope of Cannabis infused Edibles Market Expects to See Significant Growth During 2020-2026
? husain October 27, 2020
Cannabis infused Edibles Market 2020 – Latest Industry Demand Analysis and Business Opportunities across the globe.
The impactful research study on global Cannabis infused Edibles Market 2020 done by research team and latest research study report added into database of market research vision. The Cannabis infused Edibles market research study describes worldwide Business Opportunities, Important Drivers, Key Challenges, Market Risks in brief.
Get Latest Sample Report of Global Cannabis infused Edibles Market 2020-2026: https://www.marketresearchvision.com/request-sample/544973
Global Cannabis infused Edibles Market 2020 research study includes –
Some significant activities of the current market size for the worldwide Cannabis infused Edibles market It presents a point by point analysis
This report centers around the Cannabis infused Edibles-business status, presents –
volume and worth
Important key players – Koios Beverage Corp., Medically Correct, LLC., Mentor Capital, Inc., LOL Edibles, HempFoods, Heineken, Plus Products, VCC BRANDS, Baked Bros, Dixie, NightFood Holdings, Inc., Bhang Corporation, KIVA CONFECTIONS, Kaya Holdings, Inc., Cannabis Energy Drink, Canopy Growth Corp, KANEH CO, Organigram Holdings Inc., Lord Jones
Product type with its subtype – Food, Beverage, Others
Application areas/Consumers/End users – Yield Monitoring, Field Mapping, Crop Scouting, Weather Tracking & Forecasting, Irrigation Management, Inventory Management, Farm Labor Management
Regions – North America, Europe, Asia-Pacific, South America, Middle East & Africa
Rather sloppy about it too. Looks like some of those discounted shares maybe were given to some overly trusting/ambitious "partners" that they decided not to inform the state about, resulting in the loss of two licenses for farming and processing marijuana that they clearly stated that they owned here but now looks like a grow house of cards.
https://www.oregon.gov/olcc/Docs/stipulated_settlements/marijuana/SSA_October2020_MJ.pdf
KAYS LOSES BOTH LICENCES TO FARM AND PROCESS in Oregon! Well lookey here! Wouldn't ya know it the Kaya creeps have lost two licenses from playing crooked ball with the state and some unsuspecting investors.
https://www.oregon.gov/olcc/Docs/stipulated_settlements/marijuana/SSA_October2020_MJ.pdf
Sunstone Marketing Partners, LLC Robert Frey, Member/Manager dba KAYA FARMS (#A8DF) (Processor)
OAR 845-025-1160(4) – On or before August 18, 2018, Licensee or Licensee’s employees, agents, or representatives failed to notify the Commission of a change to its corporate or ownership structure, or in who has a financial interest in the business prior to making such a change when Bruce Burwick and/or MJAI Oregon 1, LLC obtained an ownership and/or financial interest in the licensed business without notification to or approval from the Commission prior to making the changes. Bruce Burwick obtained an ownership interest, as described in OAR 845-025- 1045(3), and/or a financial interest, as defined in OAR 845-025-1015(26), in the licensed business by becoming a 50% member of the licensed entity, Sunstone Management Partners, LLC, and/or providing it with approximately $3 million in capital investments. MJAI Oregon 1, LLC obtained an ownership interest, as described in OAR 845-025-1045(3), and/or financial interest, as defined in OAR 845-025-1015(26), in the licensed business by, including but not limited to: entering into a contract or contracts that allowed them to operate the licensed business, and subsequently operating the business, such that the performance of the business caused, or was capable of causing, them to benefit or suffer financially; and/or allowed them to exercise control over the business; incur debt or be entitled to incur debt or a similar obligation on behalf of the business; and/or enter into or be entitled to enter into a contract or a similar obligation on behalf of the business, other than as employees acting under the direction of the owner.
(Category I)
OAR 845-025-7520(1)(d) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed to properly tag all marijuana inventory with a unique identification (UID) tag pursuant to the system requirements of METRC Cannabis Tracking System when there were several jars of marijuana in a room on the licensed premises that did not have UID tags on them.
(1ST Level Category III)
OAR 845-025-1410(3)(b) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed during all hours when Licensee was not operating to keep all useable marijuana enclosed in an area that was secured with a steel door with a steel frame when several jars of marijuana were in a room with glass exterior doors.
SYNOPSIS: An investigation showed that Licensee Sunstone Partners had entered into an agreement with Kaya Farms whereby Kaya Farms was able to obtain ownership and financial interests in the licensed business without prior approval by the Commission. Pursuant to the agreement, Kaya Farms operated and exercised control over the licensed business and Licensee was no longer involved. A site inspection revealed additional Category III violations at both premises. Licensee agreed to surrender its license, and warranted that any sale of the business would not be to the entity that had obtained the unapproved interest in the business.
.
TERMS OF AGREEMENT
1. Licensee accepts responsibility for the violations as set out in the Notice. Violation Number One was Licensee’s first Category I violation. Violations Number Two and Three were Licensee’s first and second Category III violations within two years.
2. Commission staff proposed license cancellation for these violations. Licensee has begun the process of selling the business. Licensee will surrender its license on the date the transfer of ownership of the business is completed or at 12:00 PM on January 13, 2021, whichever is earlier.
3. Licensee understands and agrees that the Commission is not representing or guaranteeing that a new owner will have an approved license on or before January 13, 2021. Licensee understands and agrees that any new owner will have to fully complete the application process, and the application has to receive final approval by the Commission, prior to a license being issued.
4. Licensee agrees, represents, and warrants that the business will not be sold to the entity and/or individuals alleged to have obtained an unapproved financial and/or ownership interest in the licensed business, namely MJAI Oregon 1, LLC or Bruce Burwick, or to Kaya Holdings, Inc., the parent company of MJAI Oregon 1, LLC, or any parent, subsidiary, affiliate, or successor of Kaya Holdings, Inc.
5. Each licensee agrees to accept a letter of reprimand for the violations specified above. This letter of reprimand will become a permanent part of the licensee’s
Commission file and may be considered in any future application for any license or permit by the licensee.
6. Licensee hereby relinquishes any and all interest in any marijuana items in its inventory that have not been transferred before the effective date of license surrender, and agrees that the Commission may seize and destroy any such marijuana items.
7. Licensee withdraws its Request for Hearing in this matter.
8. In consideration of the forbearance stated herein, Licensee agrees to release and waive any and all claims of any kind, known or unknown, past or future, against the State of Oregon or its agencies, instrumentalities, employees, officers, or agents arising out of the matters set forth in the Third Amended Notice (including any prior versions of the Third Amended Notice) or this Settlement Agreement and the final order based hereon, including but not limited to any claim under federal or state law for damages, declaratory or equitable relief, under 42 USC §1983 et. seq., and for attorneys fees or costs.
9. The terms of this Settlement Agreement and the Final Order entered based on this Agreement are binding on Licensee and any of its agents, employees, representatives, successors or assigns.
10. This agreement is conditioned upon final approval of the Oregon Liquor Control Commission and will be reviewed by the Commissioners at their October 2020 Commission Meeting. If the agreement is not accepted and approved in its entirety by the Commission it is deemed null and void and Licensee’s hearing rights, if any, will be restored. If the agreement is accepted and approved in its entirety by the Commission, Licensee waives any and all rights to a contested case hearing under the Administrative Procedures Act (ORS Chapter 183) and to judicial review, or to otherwise challenge this agreement and the final order.
Sunstone Marketing Partners, LLC Robert Frey, Member/Manager dba KAYA FARMS (#035C) (Producer)
OAR 845-025-1160(4) – On or before August 29 18, 2018, Licensee or Licensee’s employees, agents, or representatives failed to notify the Commission of a change to its corporate or ownership structure, or in who has a financial interest in the business prior to making such a change when Bruce Burwick and/or MJAI Oregon 1, LLC obtained an ownership and/or financial interest in the licensed business without notification to or approval from the Commission prior to making the changes. Bruce Burwick obtained an ownership interest, as described in OAR 845-025- 1045(3), and/or a financial interest, as defined in OAR 845-025-1015(26), in the licensed business by becoming a 50% member of the licensed entity, Sunstone Management Partners, LLC, and/or providing it with approximately $3 million in capital investments. MJAI Oregon 1, LLC obtained an ownership interest, as described in OAR 845-025- 1045(3), and/or financial interest, as defined in OAR 845-025-1015(26), in the licensed business by, including but not limited to: entering into a contract or contracts that allowed them to operate the licensed business, and subsequently operating the business, such that the performance of the business caused, or was capable of causing, them to benefit or suffer financially; and/or allowed them to exercise control over the business; incur debt or be entitled to incur debt or a similar obligation on behalf of the business; and/or enter into or be entitled to enter into a contract or a similar obligation on behalf of the business, other than as employees acting under the direction of the owner.
(Category I)
OAR 845-025-7520(1)(c), (d) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed to properly tag all marijuana inventory and marijuana plants that were at least twenty four inches or identified as female with unique identification (UID) tags pursuant to the system requirements of METRC Cannabis Tracking System when there were bags of marijuana trim in a freezer, marijuana in two different drying rooms, and immature marijuana plants that were identified as female on the licensed premises that did not have UID tags on them.
(1st Level Category III
OAR 845-025-1410(3)(b) - On or about July 18, 2019, Licensee or Licensee’s employees, agents, or representatives failed during all hours when Licensee was not operating to keep all useable marijuana enclosed in an area that was secured with a steel door with a steel frame when marijuana was stored in rooms that did not have steel doors and the exterior door leading into the licensed premises was not a steel door with a steel frame.
(1st Level Category III)
SYNOPSIS: An investigation showed that Licensee Sunstone Partners had entered into an agreement with Kaya Farms whereby Kaya Farms was able to obtain ownership and financial interests in the licensed business without prior approval by the Commission. Pursuant to the agreement, Kaya Farms operated and exercised control over the licensed business and Licensee was no longer involved. A site inspection revealed additional Category III violations at both premises. Licensee agreed to surrender its license, and warranted that any sale of the business would not be to the entity that had obtained the unapproved interest in the business.
TERMS OF AGREEMENT
1. Licensee accepts responsibility for the violations as set out in the Notice. Violation Number One was Licensee’s first Category I violation. Violations Number Two and Three were Licensee’s first and second Category III violations within two years.
2. Commission staff proposed license cancellation for these violations. Licensee has begun the process of selling the business. Licensee will surrender its license on the date the transfer of ownership of the business is completed or at 12:00 PM on January 13, 2021, whichever is earlier.
3. Licensee understands and agrees that the Commission is not representing or guaranteeing that a new owner will have an approved license on or before January 13, 2021. Licensee understands and agrees that any new owner will have to fully complete the application process, and the application has to receive final approval by the Commission, prior to a license being issued.
4. Licensee agrees, represents, and warrants that the business will not be sold to the entity and/or individuals alleged to have obtained an unapproved financial and/or ownership interest in the licensed business, namely MJAI Oregon 1, LLC or Bruce Burwick, or to Kaya Holdings, Inc., the parent company of MJAI Oregon 1, LLC, or any parent, subsidiary, affiliate, or successor of Kaya Holdings, Inc.
5. Each licensee agrees to accept a letter of reprimand for the violations specified above. This letter of reprimand will become a permanent part of the licensee’s Commission file and may be considered in any future application for any license or permit by the licensee.
6. Licensee hereby relinquishes any and all interest in any marijuana items in its inventory that have not been transferred before the effective date of
license surrender, and agrees that the Commission may seize and destroy any such marijuana items.
7. Licensee withdraws its Request for Hearing in this matter.
8. In consideration of the forbearance stated herein, Licensee agrees to release and waive any and all claims of any kind, known or unknown, past or future, against the State of Oregon or its agencies, instrumentalities, employees, officers, or agents arising out of the matters set forth in the Third Amended Notice (including any prior versions of the Third Amended Notice) or this Settlement Agreement and the final order based hereon, including but not limited to any claim under federal or state law for damages, declaratory or equitable relief, under 42 USC §1983 et. seq., and for attorneys fees or costs.
9. The terms of this Settlement Agreement and the Final Order entered based on this Agreement are binding on Licensee and any of its agents, employees, representatives, successors or assigns.
10. This agreement is conditioned upon final approval of the Oregon Liquor Control Commission and will be reviewed by the Commissioners at their October 2020 Commission Meeting. If the agreement is not accepted and approved in its entirety by the Commission it is deemed null and void and Licensee’s hearing rights, if any, will be restored. If the agreement is accepted and approved in its entirety by the Commission, Licensee waives any and all rights to a contested case hearing under the Administrative Procedures Act (ORS Chapter 183) and to judicial review, or to otherwise challenge this agreement and the final order.
International Cannabis Company
Kaya Holdings, Inc. Launches
$4,000,000 Rule 506(c) Offering
Use of proceeds includes launch of Kaya Farms Greece and Kaya Farms Israel Medical Cannabis Cultivation Projects, further development of Kaya Farms USA and Kaya Shack cannabis stores, and the launch of the Kaya’s cannabis extracted and infused brands.
Fort Lauderdale, FL September 16, 2020 -- Kaya Holdings, Inc. (“KAYS” or the “Company”), (OTCQB: KAYS), the first U.S. publicly traded company to vertically integrate cannabis retail, cultivation and processing operations announced today that it is seeking to raise up to $4 million through an offering to be conducted pursuant to Rule 506(c) of Regulation D promulgated under the Securities Act (the “Offering”).
Information regarding the Offering is available by accessing https://invest.kayaholdings.com ; the interactive investor portal that the Company has commissioned so that potential investors may gain access to the Private Placement Memorandum and all relevant documents, or by emailing info@kayaholdings.com
Offering Details
The Company is offering, through a Confidential Private Placement Memorandum, a maximum of one hundred and sixty (160) Units (“Units”) at an offering price of $25,000.00 per Unit. The minimum investment is $12,500.00 (one-half Unit).
Each Unit consists of:
(a) 1,000,000 shares of the Company’s common stock (“KAYS Shares”);(b) 1,000,000 one-year Class A warrants (the “Class A Warrants”), each entitling the holder to purchase one additional KAYS Share, at an exercise price of $0.075 per KAYS Share; (c) 1,000,000 two-year Class B warrants (the “Class B Warrants,” and together with the Class A Warrants, collectively, the “Warrants”), each entitling the holder to purchase one additional KAYS Share, at an exercise price of $0.125 per KAYS Share; and(d) 100,000 shares of Kaya Brands International, Inc. “KBI Shares” Kaya Brands International, Inc. is a newly-incorporated subsidiary of KAYS through which the Company intends to launch its Kaya Farms Greece and Kaya Farms Israel operations.
Each Class A Warrant entitles the holder to purchase one KAYS Share at an exercise price of $0.075 per KAYS Share for a period of one (1) year from the date the Offering is closed but are callable on thirty (30) days’ notice by the Company any time after the Offering is closed if the average closing stock price of the preceding 30 days exceeds $0.075, or the current exercise price, which may be reduced at the election of the Company.
Each Class B Warrant entitles the holder to purchase one KAYS Share at an exercise price of $0.125 per KAYS Share for a period of two (2) years from the date the final closing of the Offering is closed but are callable on thirty (30) days’ notice by the Company after nine months if the average closing stock price of the preceding 30 days exceeds $0.125 or the current exercise price, which may be reduced at the election of the Company.
“The funds from this offering will allow us to advance Kaya Farms Greece and Kaya Farms Israel,” said Craig Frank, KAYS Chairman and CEO. “These two facilities, as currently envisioned are configured to produce approximately 600,000 pounds of GMP certified, medical grade cannabis annually for potential export to the European Union and elsewhere.”
This press release is not a solicitation or offer to buy or sell securities. Under Rule 506(c), general solicitation of offerings is permitted, however, only accredited investors who meet the SEC Regulation D 501 “accredited investor” accreditation standards and who provide suitable verification of accredited status may invest into this Offering. Investments may be speculative, illiquid and carry a risk of loss. Past performance is not indicative of future results. There is no guarantee that any specific outcome will be achieved.
About Kaya Holdings, Inc.-
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the counter market under the symbol OTCQB:KAYS.
Summary of Operations
KAYS corporate structure includes the following three majority-owned subsidiaries, each responding to various demands and opportunities in the cannabis industry:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States.
Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories.
Kaya Brands International, Inc., was founded to serve as the vehicle for the Company’s non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
For more information on the KAYS Offering please access this link:
https://invest.kayaholdings.com ;
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664
SOURCE: Kaya Holdings, Inc.
KAYA SHACK (OTCQB: KAYS)
Alternative Fuels Americas, Inc.
305 S. Andrews Ave Suite 209
Fort Lauderdale, FL 33301
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
?
?
Small Company Offering and Sale of Securities Without Registration (d)
Source: Edgar (US Regulatory)
o NoneEntity Type
0001530746
Alternative Fuels Americas, Inc.
Alternative Fuels America, Inc.
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
Kaya Holdings, Inc.
Jurisdiction of Incorporation/OrganizationDELAWARE Year of Incorporation/Organization xOver Five Years Ago oWithin Last Five Years (Specify Year) oYet to Be Formed
2. Principal Place of Business and Contact InformationName of Issuer Kaya Holdings, Inc. Street Address 1Street Address 2 915 MIDDLE RIVER DRIVE, SUITE 316 CityState/Province/CountryZIP/Postal CodePhone No. of Issuer FORT LAUDERDALE FLORIDA 33304 954-534-7895
3. Related Persons
Last NameFirst NameMiddle NameFrankCraigStreet Address 1Street Address 2915 Middle River Drive, suite 316CityState/Province/CountryZIP/Postal CodeFort LauderdaleFLORIDA33304Relationship:xExecutive OfficerxDirectoroPromoterClarification of Response (if Necessary)
Last NameFirst NameMiddle NameSchwarzCarrieStreet Address 1Street Address 2915 Middle River Drive, Suite 316CityState/Province/CountryZIP/Postal CodeFort LauderdaleFLORIDA33304Relationship:oExecutive OfficerxDirectoroPromoterClarification of Response (if Necessary)
Last NameFirst NameMiddle NameArimanyJordiStreet Address 1Street Address 2915 Middle River Drive, Suite 316CityState/Province/CountryZIP/Postal CodeFort LauderdaleFLORIDA33304Relationship:oExecutive OfficerxDirectoroPromoterClarification of Response (if Necessary)
Last NameFirst NameMiddle NameBerwickBruceStreet Address 1Street Address 2915 Middle River Drive, Suite 516CityState/Province/CountryZIP/Postal CodeFort LauderdaleFLORIDA33304Relationship:oExecutive OfficerxDirectoroPromoterClarification of Response (if Necessary)
4. Industry GroupoAgriculture Health CareoRetailing Banking & Financial Services oBiotechnologyoRestaurants oCommercial Banking oHealth Insurance Technology oInsurance oHospitals & Physicians oComputers oInvesting oPharmaceuticals oTelecommunications oInvestment Banking oOther Health Care oOther Technology oPooled Investment Fund
Travel oOther Banking & Financial ServicesoManufacturing oAirlines & Airports Real Estate oLodging & Conventions oCommercial oTourism & Travel Services oConstruction oOther Travel oREITS & FinancexOther oResidential oOther Real Estate oBusiness Services Energy oCoal Mining oElectric Utilities oEnergy Conservation oEnvironmental Services oOil & Gas oOther Energy
5. Issuer SizeRevenue RangeAggregate Net Asset Value RangeoNo RevenuesoNo Aggregate Net Asset Valueo$1 - $1,000,000o$1 - $5,000,000x$1,000,001 - $5,000,000o$5,000,001 - $25,000,000o$5,000,001 - $25,000,000o$25,000,001 - $50,000,000o$25,000,001 - $100,000,000o$50,000,001 - $100,000,000oOver $100,000,000oOver $100,000,000oDecline to DiscloseoDecline to DiscloseoNot ApplicableoNot Applicable
6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)oRule 504(b)(1) (not (i), (ii) or (iii))oRule 505oRule 504 (b)(1)(i)oRule 506(b)oRule 504 (b)(1)(ii)xRule 506(c)oRule 504 (b)(1)(iii)oSecurities Act Section 4(a)(5) oInvestment Company Act Section 3(c)
7. Type of FilingxNew NoticeDate of First Sale xFirst Sale Yet to OccuroAmendment
8. Duration of OfferingDoes the Issuer intend this offering to last more than one year?oYesxNo
9. Type(s) of Securities Offered (select all that apply)oPooled Investment Fund InterestsxEquityoTenant-in-Common SecuritiesoDebtoMineral Property SecuritiesxOption, Warrant or Other Right to Acquire Another SecurityxSecurity to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire SecurityoOther (describe)
10. Business Combination TransactionIs this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?oYesxNo Clarification of Response (if Necessary)
11. Minimum InvestmentMinimum investment accepted from any outside investor$ 12500 USD
12. Sales Compensation
RecipientRecipient CRD NumberoNone (Associated) Broker or DealeroNone(Associated) Broker or Dealer CRD NumberoNone Street Address 1Street Address 2 CityState/Province/CountryZIP/Postal Code State(s) of SolicitationoAll States
13. Offering and Sales AmountsTotal Offering Amount$ 4000000 USDo IndefiniteTotal Amount Sold$ 00 USD Total Remaining to be Sold$ 4000000 USDo Indefinite Clarification of Response (if Necessary)
14. InvestorsoSelect if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:0
15. Sales Commissions & Finders’ Fees ExpensesProvide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USDxEstimateFinders' Fees$ 0 USDxEstimate Clarification of Response (if Necessary)
16. Use of ProceedsProvide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
$ 0 USDx
Interesting here at this depressed price. Seems no dilution and private offering of 25mil. Hmmm
Kaya Holdings Greek and Israeli Medical Cannabis Projects Zoom Update Today at 2:00 PM EST
September 2, 2020, 12:00 PM EDT·9 mins read
KAYS to report to shareholders on Q-2 results of operations, progress of medical cannabis cultivation projects in Greece and Israel, and other business developments
FORT LAUDERDALE, FL / ACCESSWIRE / September 2, 2020 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), the first U.S. publicly traded company to vertically integrate cannabis retail, cultivation and processing operations confirmed that the online shareholder webinar will today Wednesday, September 2, 2020 at 2:00 PM Eastern Time.
Seating is limited so please register now using the following link to reserve your place for the program:
https://us02web.zoom.us/webinar/register/WN_fdKpjk8oTnWZeOzIwc2klw
After registering, you will receive a confirmation email containing information about joining the webinar. If you do not receive a confirmation email, please contact us via email at info@kayaholdings.com and we will assist you.
Participants will be able to view the presentation live on their computer, tablet or smartphone. The presentation is expected to last between 60-90 minutes and will feature online live discussion with Craig Frank, KAYS Chairman and CEO and W. David Jones, Senior Advisor for Business Development and Financial Operations, as well as live onsite reports from Management and Staff in Oregon, Greece and Israel.
Topics to be covered will include:
Results of Financial Operations for the three and six month periods ending June 30, 2020, as reported on KAYS recently filed Form 10-Q.
Reports on progress of our subsidiary Kaya Brands International, Inc.'s medical marijuana cultivation projects in Greece and Israel. These two facilities, as currently envisioned (and after obtaining successful financing, completing construction and obtaining final requisite licensing), are configured to produce approximately 600,000 pounds of GMP Certified, Premium Medical Grade, Cannabis annually for potential export to the European Union and elsewhere.
Other general business developments.
"We have spent the last two years planning on the expansion of our business by developing international opportunities for KAYS. Management had determined that international projects would enable KAYS to leverage its 6+ years in the U.S. cannabis industry to foster growth and build increase shareholder value," stated KAYS CEO Craig Frank. "We look forward on reporting KAYS' progress shareholders."
About Kaya Holdings, Inc. (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority-owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the-counter market under the symbol OTCQB:KAYS.
Summary of Operations
KAYS corporate structure includes the following three majority-owned subsidiaries, each responding to various demands and opportunities in the cannabis industry:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States. Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories. Kaya Brands International, Inc., was founded to serve as the vehicle for the Company's non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
Webinar Reminder
Kaya Holdings:
Greek and Israeli Medical Cannabis Projects Zoom Update to be Held September 2, 2020
KAYS to report to shareholders on
Q-2 results of operations, progress of medical cannabis cultivation projects in Greece and Israel, and other business developments
This is a reminder that the Kaya Holdings Webinar will be Wednesday, September 2, 2020 at 2:00 PM Eastern Time.
Seating is limited so please register now using the following link to reserve your place for the program:
?
https://us02web.zoom.us/webinar/register/WN_fdKpjk8oTnWZeOzIwc2klw
After registering, you will receive a confirmation email containing information about joining the webinar. If you do not receive a confirmation email, please contact us via email at info@kayaholdings.com and we will assist you.
Participants will be able to view the presentation live on their computer, tablet or smartphone. The presentation is expected to last between 60-90 minutes and will feature online live discussion with Craig Frank, KAYS Chairman and CEO and W. David Jones, Senior Advisor for Business Development and Financial Operations, as well as live onsite reports from Management and Staff in Oregon, Greece and Israel.
?
Note: Envisioned Facilities for Greek and Israel not yet constructed and for conceptual purposes only.
Please follow this link to see a video of how we are operating with our Covid-19 inspired safety enhancements to serve our medical and recreational marijuana customers via instore sales, curbside pickup and free delivery:
****************************************************
About Kaya Holdings, Inc.- (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the counter market under the symbol OTCQB:KAYS.
Summary of Operations
KAYS corporate structure includes the following three majority-owned subsidiaries, each responding to various demands and opportunities in the cannabis industry:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States. Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories. Kaya Brands International, Inc., was founded to serve as the vehicle for the Company's non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
Marijuana Holdings Americas, Inc.- U.S. Cannabis Operations
Kaya Shack™ Retail Cannabis Stores
In 2014, KAYS became the first United States publicly-traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates two Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon, and is in the process of relocating a third retail cannabis license to serve as a delivery hub for the Eugene and Southern Oregon Cannabis Market.
Kaya Farms™
Eugene, Oregon Indoor Grow, Processing & Cannaceutical Facility: The Company owns a 12,000 square foot Kaya Farms™ indoor grow and manufacturing facility in Eugene, Oregon, which serves as the Company’s center for cultivation trials, method experiments, genetic research and cannabis infused product development. The Company is presently conducting limited operations at this location under a Management Agreement with Sunstone Farms, the current licensee. Pending the successful acquisition and transfer of other existing OLCC Marijuana Production and Processing licenses, KAYS intends to build out the facility and ramp up to full production.
?
Lebanon, Oregon Farm & Greenhouse Facility: KAYS owns a 26-acre parcel in Lebanon, Linn County, Oregon which it intends to construct an 85,000-square-foot Kaya Farms™ greenhouse cultivation and production facility. To date KAYS has received Linn County Zoning approvals and upon issuance of OLCC Licensing it will begin construction. The farm is intended for immediate development and provides the Company with a potential additional capacity of more than 100,000 pounds annually, to be expanded once export from Oregon to other U.S. States and foreign countries where cannabis use is legal is permitted. Kaya Farms™ operates in accordance with a Grow Operations manual, as well as manuals for compliance, employment matters and safety.
Kaya Brands USA, Inc.- Brand and Product Development
?
The Company maintains a genetics library of over 30 strains of cannabis and owns a number of proprietary brands in traditional and innovative cannabis categories.
Increasingly, brands are an important component of a vertically integrated company’s assets. The Company endeavors to create brands that are meaningful, appealing and effective communicators of the Kaya principles of quality and value. KAYS plans to have all or most brands active in 2021.
Kaya Brands International, Inc.- Foreign Cannabis Operations
After over six years of conducting "touch the plant" U.S. cannabis operations inside the strict regulatory confines of a public company, KAYS has formed a subsidiary, Kaya Brands International, Inc. ("KBI") to leverage its experience and expand into worldwide cannabis markets. KBI's current operations and initiatives include:
Kaya Kannabis- Kaya Farms™ Greece S.A. (“Kaya Farms Greece”, a Greek Corporation) is a majority owned subsidiary of KBI. The Company is in the final stages of completing their due diligence and expects to exercise their option (pursuant to terms of a previously disclosed 8-K filing) for Kaya Farms Greece to acquire a 50% interest in Greekkannabis, PC, an Athens, Greece based cannabis company which has received its license for the construction of a facility encompassing approximately 500,000 square feet of buildings on 15 acres of land outside of Athens, Greece to grow, process and export medical grade cannabis from Greece to the European Union and elsewhere.
Kaya Farms™ Israel- Kaya Shalvah LTD (“Kaya Farms Israel”, an Israeli Corporation) is a majority owned subsidiary of KBI. Kaya Farms Israel is in the process of applying to various Israeli Government Agencies for a license to grow, process and export medical grade cannabis from Israel. Upon submission of the initial application to the Israeli Cannabis Authority, Kaya Shalvah intends to submit a bid to acquire 100 Dunams (approximately 25 acres) of land in Israel that is part of Greenegev, an Israeli Government backed Cannabinoid Ecosystem in Yerucham, Israel that is envisioned to become the Silicon Valley of Medical Cannabis Production and Research.
These two facilities, as currently envisioned (and after obtaining successful financing, completing construction and obtaining final requisite licensing), are configured to produce approximately 600,000 pounds of GMP Certified, Premium Medical Grade, Cannabis annually for potential export to the European Union and elsewhere.
Canadian Franchising: KAYS has targeted Canada (the only G7 country that has legalized both medical and recreational cannabis production, sale and use on a national level) for its first international sale and operation of Kaya Shack™ cannabis store franchises, with a goal of 75-100 Kaya Shack™ Cannabis Retail locations throughout Canada through a multi-year structured rollout, subject to licensing and market conditions. KAYS has retained Toronto, Canada based law firm of Garfinkle Biderman, LLP to prepare the Franchise Disclosure Documents and related items for the sale of Kaya Shack™ cannabis store franchises in Canada. KAYS plans to ultimately expand its franchise operations to the U.S., as regulations and laws permit.
Important Disclosure
KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to marijuana. Potential investors and shareholders are cautioned that KAYS and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664
SOURCE: Kaya Holdings, Inc.
****************************************************
?
Online Shareholder Business Update, which is to be held on Wednesday, September 2, 2020 at 2:00 PM Eastern Time.
Seating is limited so please register now using the following link to reserve your place for the program:
https://us02web.zoom.us/webinar/register/WN_fdKpjk8oTnWZeOzIwc2klw
After registering, you will receive a confirmation email containing information about joining the webinar. If you do not receive a confirmation email, please contact us via email at info@kayaholdings.com and we will assist you.
A copy of the Company’s latest filings complete with pictures, store information and other data as filed with the SEC is available online at www.sec.gov
Investor Update:
To access KAYS News & SEC Filings, Level II Quotes, News sign up for notifications of
please go to www.kayaholdings.com
and add your email to our list
Unsubscribe
This message was sent to abracky@yahoo.com from info@kayaholdings.com
KAYA SHACK (OTCQB: KAYS)
Alternative Fuels Americas, Inc.
305 S. Andrews Ave Suite 209
Fort Lauderdale, FL 33301
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Kaya Holdings Inc. (OTCMKTS:KAYS) Announces the Appointment of a Veteran Pet Industry Executive to Lead Its Cannamo™ Brand of CBD Pet Products
Evan Dion | August 28, 2020
?
Through a fully integrated group of companies, Kaya Holdings Inc. (OTCMKTS:KAYS) supports the production, distribution, and selling of highly distinctive brands of cannabis products. Some of its products include vape cartridges, oils, flowers, baked goods and beverages, and cannabis-infused confections. The company also operates a seed-to-sale legal marijuana enterprise in the United States. Its success has come through the application of both sophisticated and straightforward philosophies.
The simple philosophy outlines the consistent provision of high-quality products and fair prices to reach a broad base of customers. Its vertical business fundamentals define the company’s sophisticated philosophy controls, such as brand strength, compliance, vision, and the ability to navigate the growing and complex industry successfully.
Kaya Holdings Partnership with Kaya Kannabis and the Hiring of a new CEO
The first U.S. publicly traded company has taken yet another bold move of partnering with Kaya Kannabis. Through a Memorandum of Understanding (“MOU”), KBI will acquire a 50% ownership interest in Greekkannabis. The MOU also sets a pace for KBI to offer its expertise in the cultivation, processing, and brand development of cannabis. However, KBI will have to reimburse GKC for 50% of its license application costs.
It is worth noting that KAYS Cannabis has been very successful in its operations, which run through three main majority-owned subsidiaries. They include Marijuana Holdings Americas, Inc, Kaya Brands USA, Inc, and Kaya Brands International, Inc.
In other news, Kaya Kannabis has brought on board a veteran pet industry executive to take up the roles of a CEO. Calliope Zogopoulou will be in charge of the company’s recently announced Cannamo™ brand of CBD pet products.
According to one of the Kaya Kannabis executives, Panagiotis Kinnis, Zogopoulou can establish strong business relationships. Besides, she has been doing for so many years as an operational administrator and executive of “Ambrosia Pet Food.”
“We believe she has the experience, relationships, and leadership to bring our very first product line to market in Greece and the EU,” Kinnis stressed.
The validation of the partnership and the appointment of Zogopoulou is a clear indicator of the company’s plan to incorporate the talent and opportunities necessary for tapping into the international markets.
NEWS ALERT
Kaya Holdings:
Greek and Israeli Medical Cannabis Projects Zoom Update to be Held September 2, 2020
KAYS to report to shareholders on
Q-2 results of operations, progress of medical cannabis cultivation projects in Greece and Israel, and other business developments
Fort Lauderdale, Florida -- August 25, 2020 --Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB:KAYS), the first U.S. publicly traded company to vertically integrate cannabis retail, cultivation and processing operations announced today that it has scheduled and commenced issuing reservation codes for an Online Shareholder Business Update, which is to be held on Wednesday, September 2, 2020 at 2:00 PM Eastern Time.
Seating is limited so please register now using the following link to reserve your place for the program:
?
https://us02web.zoom.us/webinar/register/WN_fdKpjk8oTnWZeOzIwc2klw
After registering, you will receive a confirmation email containing information about joining the webinar. If you do not receive a confirmation email, please contact us via email at info@kayaholdings.com and we will assist you.
Participants will be able to view the presentation live on their computer, tablet or smartphone. The presentation is expected to last between 60-90 minutes and will feature online live discussion with Craig Frank, KAYS Chairman and CEO and W. David Jones, Senior Advisor for Business Development and Financial Operations, as well as live onsite reports from Management and Staff in Oregon, Greece and Israel.
Topics to be covered will include:
1. Results of Financial Operations for the three and six month periods ending June 30, 2020, as reported on KAYS recently filed Form 10-Q.
?
Note: Envisioned Facilities for Greek and Israel not yet constructed and for conceptual purposes only.
2. Reports on progress of our subsidiary Kaya Brands International, Inc.’s medical marijuana cultivation projects in Greece and Israel. These two facilities, as currently envisioned (and after obtaining successful financing, completing construction and obtaining final requisite licensing), are configured to produce approximately 600,000 pounds of GMP Certified, Premium Medical Grade, Cannabis annually for potential export to the European Union and elsewhere.
3. Other general business developments.
“We have spent the last two years planning on the expansion of our business by developing international opportunities for KAYS. Management had determined that international projects would enable KAYS to leverage its 6+ years in the U.S. cannabis industry to foster growth and build increase shareholder value,” stated KAYS CEO Craig Frank. “We look forward on reporting KAYS’ progress shareholders.”
Please follow this link to see a video of how we are operating with our Covid-19 inspired safety enhancements to serve our medical and recreational marijuana customers via instore sales, curbside pickup and free delivery:
****************************************************
About Kaya Holdings, Inc.- (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the counter market under the symbol OTCQB:KAYS.
Summary of Operations
KAYS corporate structure includes the following three majority-owned subsidiaries, each responding to various demands and opportunities in the cannabis industry:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States. Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories. Kaya Brands International, Inc., was founded to serve as the vehicle for the Company's non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
Marijuana Holdings Americas, Inc.- U.S. Cannabis Operations
Kaya Shack™ Retail Cannabis Stores
In 2014, KAYS became the first United States publicly-traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates two Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon, and is in the process of relocating a third retail cannabis license to serve as a delivery hub for the Eugene and Southern Oregon Cannabis Market.
Kaya Farms™
Eugene, Oregon Indoor Grow, Processing & Cannaceutical Facility: The Company owns a 12,000 square foot Kaya Farms™ indoor grow and manufacturing facility in Eugene, Oregon, which serves as the Company’s center for cultivation trials, method experiments, genetic research and cannabis infused product development. The Company is presently conducting limited operations at this location under a Management Agreement with Sunstone Farms, the current licensee. Pending the successful acquisition and transfer of other existing OLCC Marijuana Production and Processing licenses, KAYS intends to build out the facility and ramp up to full production.
?
Lebanon, Oregon Farm & Greenhouse Facility: KAYS owns a 26-acre parcel in Lebanon, Linn County, Oregon which it intends to construct an 85,000-square-foot Kaya Farms™ greenhouse cultivation and production facility. To date KAYS has received Linn County Zoning approvals and upon issuance of OLCC Licensing it will begin construction. The farm is intended for immediate development and provides the Company with a potential additional capacity of more than 100,000 pounds annually, to be expanded once export from Oregon to other U.S. States and foreign countries where cannabis use is legal is permitted. Kaya Farms™ operates in accordance with a Grow Operations manual, as well as manuals for compliance, employment matters and safety.
Kaya Brands USA, Inc.- Brand and Product Development
?
The Company maintains a genetics library of over 30 strains of cannabis and owns a number of proprietary brands in traditional and innovative cannabis categories.
Increasingly, brands are an important component of a vertically integrated company’s assets. The Company endeavors to create brands that are meaningful, appealing and effective communicators of the Kaya principles of quality and value. KAYS plans to have all or most brands active in 2021.
Kaya Brands International, Inc.- Foreign Cannabis Operations
After over six years of conducting "touch the plant" U.S. cannabis operations inside the strict regulatory confines of a public company, KAYS has formed a subsidiary, Kaya Brands International, Inc. ("KBI") to leverage its experience and expand into worldwide cannabis markets. KBI's current operations and initiatives include:
Kaya Kannabis- Kaya Farms™ Greece S.A. (“Kaya Farms Greece”, a Greek Corporation) is a majority owned subsidiary of KBI. The Company is in the final stages of completing their due diligence and expects to exercise their option (pursuant to terms of a previously disclosed 8-K filing) for Kaya Farms Greece to acquire a 50% interest in Greekkannabis, PC, an Athens, Greece based cannabis company which has received its license for the construction of a facility encompassing approximately 500,000 square feet of buildings on 15 acres of land outside of Athens, Greece to grow, process and export medical grade cannabis from Greece to the European Union and elsewhere.
Kaya Farms™ Israel- Kaya Shalvah LTD (“Kaya Farms Israel”, an Israeli Corporation) is a majority owned subsidiary of KBI. Kaya Farms Israel is in the process of applying to various Israeli Government Agencies for a license to grow, process and export medical grade cannabis from Israel. Upon submission of the initial application to the Israeli Cannabis Authority, Kaya Shalvah intends to submit a bid to acquire 100 Dunams (approximately 25 acres) of land in Israel that is part of Greenegev, an Israeli Government backed Cannabinoid Ecosystem in Yerucham, Israel that is envisioned to become the Silicon Valley of Medical Cannabis Production and Research.
These two facilities, as currently envisioned (and after obtaining successful financing, completing construction and obtaining final requisite licensing), are configured to produce approximately 600,000 pounds of GMP Certified, Premium Medical Grade, Cannabis annually for potential export to the European Union and elsewhere.
Canadian Franchising: KAYS has targeted Canada (the only G7 country that has legalized both medical and recreational cannabis production, sale and use on a national level) for its first international sale and operation of Kaya Shack™ cannabis store franchises, with a goal of 75-100 Kaya Shack™ Cannabis Retail locations throughout Canada through a multi-year structured rollout, subject to licensing and market conditions. KAYS has retained Toronto, Canada based law firm of Garfinkle Biderman, LLP to prepare the Franchise Disclosure Documents and related items for the sale of Kaya Shack™ cannabis store franchises in Canada. KAYS plans to ultimately expand its franchise operations to the U.S., as regulations and laws permit.
Important Disclosure
KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to marijuana. Potential investors and shareholders are cautioned that KAYS and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664
SOURCE: Kaya Holdings, Inc.
****************************************************
?
Online Shareholder Business Update, which is to be held on Wednesday, September 2, 2020 at 2:00 PM Eastern Time.
Seating is limited so please register now using the following link to reserve your place for the program:
https://us02web.zoom.us/webinar/register/WN_fdKpjk8oTnWZeOzIwc2klw
After registering, you will receive a confirmation email containing information about joining the webinar. If you do not receive a confirmation email, please contact us via email at info@kayaholdings.com and we will assist you.
A copy of the Company’s latest filings complete with pictures, store information and other data as filed with the SEC is available online at www.sec.gov
Investor Update:
To access KAYS News & SEC Filings, Level II Quotes, News sign up for notifications of
please go to www.kayaholdings.com
and add your email to our list
Unsubscribe
This message was sent to abracky@yahoo.com from info@kayaholdings.com
KAYA SHACK (OTCQB: KAYS)
Alternative Fuels Americas, Inc.
305 S. Andrews Ave Suite 209
Fort Lauderdale, FL 33301
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
OTCQB:KAYS NEWS ALERT
International Cannabis Company Kaya Holdings’ Greek CBD Pet Products Partnership Hires Prominent Industry Veteran as CEO
Fort Lauderdale, Florida August 12, 2020, - Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB.KAYS), the first U.S. publicly traded company to vertically integrate cannabis retail, cultivation and processing, announced today that its Greek Partnership, Kaya Kannabis, has hired a veteran pet industry executive to lead its recently announced Cannamo™ brand of CBD pet products.
?
In Hellenic mythology, Ambrosia used to be the food of the Gods, considered to
grant immortality to whoever consumed it. Ambrosia Pet Foods is a well recognized brand
from Greece, and Kaya Kannabis is seeking to leverage this success for the marketing
of the Cannamo brand of CBD pet products.
“We are pleased to announce the appointment of Calliope Zogopoulou as the CEO of Cannamo™”, said Panagiotis Kinnis, one of the founding partners of Greek Kannabis and a Kaya Kannabis executive. “We believe she has the experience, relationships, and leadership to bring our very first product line to market in Greece and the EU”.
Ms. Zogopoulou is the co-founder, active partner, operational administrator and executive of “Ambrosia Pet Food” (https:// www.ambrosiapetfood.com/), a producer of premium-quality dry pet food. Over the years she has developed strong relationships with some of the largest pet-food distributors in Greece, as well contacts in Romania, Russia, Israel, and major E.U. countries.
“I am enthusiastic and excited by the opportunities I believe we can create with the Cannamo™ brand,” shared Calliope Zogopoulou. “CBD in pet food can provide our beloved pets with pain relief, better digestion and overall health. I am so pleased to help bring this newly recognized wellness product to Greek pet owners, and beyond.”
“Once again our Greek partners have demonstrated their ability to deliver at an extremely high level, providing our joint venture, Kaya Kannabis, with opportunity and access”, added KAYS CEO, Craig Frank, “We were also pleased to be able to activate our partnership with Day Three Labs to source product and provide logistical support. This deal serves to validate our plan to integrate talent and opportunities for a strong KAYS international presence”.
*****************************************************
Kaya Holdings files periodic reports with the U.S. Securities and Exchange Commission (the “SEC”). A copy of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, complete with pictures, store information and product testing, as well as our other periodic reports filed with the SEC, is available online at www.sec.gov or at www.otcmarkets.com.
To be advised of all upcoming News Releases and shareholder emails please go to www.kayaholdings.com and add your email to our notification list.
Also, please follow this link to see a video of how we are operating with our Covid-19 inspired safety enhancements to serve our medical and recreational marijuana customers via instore sales, curbside pickup and free delivery:
https://www.youtube.com/watch?v=-6TpVuFzxM8
****************************************************
About Kaya Holdings, Inc.- (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the counter market under the symbol OTCQB:KAYS.
KAYS Cannabis operations are conducted under three main majority-owned subsidiaries as further detailed below:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States.
Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories.
Kaya Brands International, Inc., was founded to serve as the vehicle for the Company’s non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
Marijuana Holdings Americas, Inc.-
U.S. Cannabis Operations
Kaya Shack™ Retail Cannabis Stores
In 2014, KAYS became the first United States publicly traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates two Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon, and maintains an active third OLCC Marijuana Retail License which it is seeking to move to its Eugene, Oregon Kaya Farms Indoor Production and Processing Facility so that the Company may offer a “Kaya Farm Store” and also serve as a retail delivery hub for Eugene, Oregon.
Kaya Farms™
Eugene, Oregon Indoor Grow, Processing & Cannaceutical Facility: KAYS has developed its own proprietary Kaya Farms™ strains of cannabis, which it grows and produces (together with edibles and other cannabis derivatives) at its 12,000 square foot indoor grow and cannabis manufacturing facility in Eugene, Oregon, capable of producing approximately 1,500 pounds of premium cannabis annually, with the capacity for expansion. The Company also plans to use the space for production of oils, concentrates, extracts, edibles, and cannaceuticals.
KAYS is currently conducting limited operations at the facility pending acquisition of both a production and processing license in the secondary market for the facility, and the requisite approval by the Oregon Liquor Control Commission (the "OLCC", the Oregon state regulating agency which regulates legal cannabis production and licensing matters) to transfer the licenses to KAYS.
In the interim the facility is operationg under a Conditional Letter of Authority granted by the OLCC to operate the facility, and KAYS has received documentation from the OLCC confirming that both of the pending Kaya Farms License renewals from 2019 have been approved so that Sunstone may process a current renewal application for the upcoming license year allowing for resolution of the licensing. For more detailed information please see the most recent Quarterly Filing for KAYS.
Lebanon, Oregon Farm & Greenhouse Facility: KAYS owns a 26-acre parcel in Lebanon, Linn County, Oregon which it intends to construct a 85,000-square foot Kaya Farms™ greenhouse cultivation and production facility. To date KAYS has received Linn County Zoning approvals and upon issuance of OLCC Licensing it will begin construction. The farm is intended for immediate development and provides the Company with a potential additional capacity of more than 100,000 pounds annually, to be expanded once export from Oregon to other U.S. States and foreign countries where cannabis use is legal is permitted. Kaya Farms™ operates in accordance with a Grow Operations manual, as well as manuals for compliance, employment matters and safety.
?
Kaya Brands USA, Inc.-
Brand and Product Development
The Company maintains a genetics library of over 30 strains of cannabis and owns a number of proprietary brands in traditional and innovative cannabis categories including Kaya Buddies™ pre-rolls, Really Happy Glass™ cannabis accessories, and Kaya Gear™, company related and cannabis centric fashion. These brands are currently available at Kaya Shack™ stores.
?
The Company has made advances in the development of its Kumba Extracts™, Syzygy Extracts™, Pakalolo Juice Company™ Soothe Topicals™, Tony Giggles Pleasure Foods™ (frozen infused Italian entrees), Uptown Shaman™ (cannaceuticals), and Kaya Yums™ (chocolates, gummies, power bars) brands. and Kaya Yums™ brands of extracts, oils, vape cartridges, beverages and a variety of edibles, respectively. Pending approval of our production and processing license, KAYS intends to begin a multi-state rollout planned in 2020 to the extent permitted by U.S. legal infrastructure. These brands are intended for all Kaya Shack™ stores, both corporate owned and franchised.
Kaya Brands International, Inc.-
Foreign Cannabis Operations
After over five years of conducting "touch the plant" U.S. cannabis operations inside the strict regulatory confines of a public company, KAYS has formed a subsidiary, Kaya Brands International, Inc. ("KBI") to leverage its experience and expand into worldwide cannabis markets. KBI's current operations and initiatives include:
Canadian Franchising
KAYS has targeted Canada for its first international sale and operation of Kaya Shack™ cannabis store franchises. KAYS has entered into an area representation agreement with The Franchise Academy (a leading Canadian Franchise Development and Sales Group) to implement the Kaya Shack™Retail Cannabis Store program in Canada (the only G7 country that has legalized both medical and recreational cannabis production, sale and use on a national level). The agreement targets 75-100 Kaya Shack™ Cannabis Retail locations throughout Canada through a multi-year structured rollout, subject to licensing and market conditions.
The Franchise Academy (http://www.franchiseacademy.ca) and its founder Shawn Saraga, is a member and national sponsor of the Canadian Franchise Association. With over 15 years of industry experience and having successfully closed over 700 franchise agreements and leases across Canada, the Franchise Academy has the knowledge, expertise, network and dedication to assist select franchisors enter the Canadian market.
Additionally, KAYS has retained Toronto, Canada based law firm of Garfinkle Biderman, LLP to prepare the Franchise Disclosure Documents and related items for the sale of Kaya Shack™ cannabis store franchises in Canada. We expect the franchise sale and placement effort throughout Canada to progress over the next 3-24 months. KAYS plans to ultimately expand its franchise operations to the U.S., as regulations and laws permit.
Kaya Kannabis- Kaya Farms™ Greece
KAYS has entered into a Memorandum of Understanding ("MOU") setting forth an agreement in principle for KBI to acquire a 50% ownership interest in Greekkannabis, PC ("GKC"). GKC is a recently formed Athens, Greece based cannabis company which has applied for and is awaiting issuance of a medical cannabis cultivation, processing and export license from the Greek government.
The MOU sets forth an agreement in principle, pursuant to which in consideration for KBI providing the necessary expertise related to cannabis cultivation, processing, brand development and other matters, KBI will have the right to acquire a 50% ownership interest in GKC by reimbursing GKC for 50% of its license application costs (with allowances for KBI's expenses as well). Consummation of the transaction contemplated by the MOU is subject to, among other customary conditions, satisfactory completion by KBI of its due diligence review of GKC, the drafting, execution and delivery of definitive transaction documentation and final license approval and issuance by the Greek government.
GKC plans to establish its cannabis cultivation and processing facility on land already identified outside of Athens. Project management envisages 3 stages of development, each comprised of 125,000 square feet of light-deprivation greenhouse cultivation. Each phase is expected to produce 93,600 pounds of premium medical cannabis, for an anticipated total project capacity of not less than 280,0000 pounds annually for distribution throughout Europe and other select markets.
KAYS and KBI are represented in Greece by the Athens based law firm of Dalakos Fassolis Theofanopoulos (https://dftlaw.gr/). The firm has developed a long-established and well-respected commercial legal practice and has developed a wide international network of correspondent relationships with overseas law offices throughout the world.
Important Disclosure: KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to marijuana. Potential investors and shareholders are cautioned that KAYS and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664
SOURCE: Kaya Holdings, Inc.
****************************************************
?
Sign up and watch your email for notifications after we confirm the date and time of the next KAYS webinar and conference call to take questions on KAYS operations and development plans. Interested parties are advised to go to www.kayaholdings.com and register for KAYS updates; a confirmation email and participation code will be sent out to all shareholders and interested parties as soon as the date is set.
A copy of the Company’s latest filings complete with pictures, store information and other data as filed with the SEC is available online at www.sec.gov
Investor Update:
To access KAYS News & SEC Filings, Level II Quotes, News sign up for notifications of
please go to www.kayaholdings.com
and add your email to our list
Unsubscribe
This message was sent to abracky@yahoo.com from info@kayaholdings.com
KAYA SHACK (OTCQB: KAYS)
Alternative Fuels Americas, Inc.
305 S. Andrews Ave Suite 209
Fort Lauderdale, FL 33301
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Kaya Holdings Inc. (OTCMKTS:KAYS) Partners With Day Three Labs To Develop CBD Pet Products For European Market
Published
1 day ago
on
August 4, 2020
By
Ward Sport
Kaya Holdings Inc. (OTCMKTS:KAYS) announced a strategic partnership agreement with the Denver-based cannabis innovation lab, Day Three Labs, which has research operation In Ra’anana, Israel.
Kaya collaborating with DTL to develop pet products
The companies will concentrate on their first collaborative operation of sourcing and developing various CBD supplements for pets for distribution across Europe through Kaya’s Greece joint Venture, Kaya Kannabis. Also, the Day Three Labs principals Rafi Cohen and Joshua Rubin will be serving as advisory board members of Kaya Shalvah, which is Kaya Holding’s growing and processing project expected to be constructed in Isreal.
Craig Frank, the CEO of Kaya Holdings, stated that they were delighted to work with Day Three Labs on various projects of common interest. He added that the association of Kaya with DTL will bring exclusive product development and association in the cannabis scientific space in Israel and thus benefit their service and experience. Frank said that most importantly, the relationship shows the commitment regarding the Kaya Shalvah project and the ability to collaborate with partners in the cannabis sector.
DTL CEO, Joshua Rubin said that the partnership with Kaya solidifies their efforts of driving innovation across the global cannabis space. He added that they were delighted to cooperate on introducing unique and differentiated products to the cannabis market, beginning with CBD products. Rubin concluded that they look forward to offering their cannabis knowledge to the Kaya Shalvah Advisory Board to drive value.
Kaya introduces CBD pet products in Greece
Kaya Holding’s subsidiary Kaya Brands International in partnership with its joint venture partner Greekkannabis has rolled out CBD per products in Greece and neighboring countries in Europe under the Cannamo brand. With the help of DTL, Kaya Brands developed pet product to meet demand identified by Greekkannabis.
The three companies will play a vital role in marketing of the Cannamo brand for enhanced penetration. Kaya CEO stated that Cannamo brand was a result of collaborative efforts in establishing the company’s expansion globally.
RELATED TOPICS:CRAIG FRANKJOSHUA RUBINKAYA HOLDINGS INC.KAYA HOLDINGS INC. (OTCMKTS:KAYS)OTCMKTS:KAYS
Kaya Brands International, Inc, A Subsidiary Of Kaya Holdings Inc (OTCMKTS:KAYS), And Greekkannabis Will Introduce CBD Pet Products Under Cannamo Brand
?
Published
2 days ago
on
July 28, 2020
By
Melissa Kay
Kaya Brands International, Inc. (KBI), an auxiliary of Kaya Holdings Inc (OTCMKTS:KAYS), along with its JV partner – Greekkannabis (GKC) will roll out cannabidiol pet products under the brand – Cannamo in Greece and adjoining nations in Europe.
Involves Day Three Labs
KBI developed the Cannomo brand to satisfy the demand identified by GKC. The company also involved Day Three Labs (DTL), a company based in Israeli, developing the Cannamo brand.
GKC will contribute experience gained in the pet supplement and pet food industry in Greece for the success of this innovative brand. The three partners will play a vital role in introducing the Cannamo brand and facilitating its penetration.
Craig Frank, CEO of Kayak, said the Cannamo brand is a result of the three players’ broader cooperation to establish a large company for global expansion. The three leading players leveraged their strengths in the development and commercialization of the Cannamo brand and make its implementation simple and effective.
Kaya Kannabis, a JV between GKC and Kaya, will nurture relationships with customers for CBD products introduced by the team while rigorous efforts are put in to create a marketing strategy targeted at the EU. Co-founder of GKC, Elias Kammenos, said the launch of CBD pet products will generate revenue streams while a medical cannabis facility is constructed in Greece. It will also familiarize its brands in the EU because plans are underway to introduce THC products.
DTL’s principals – Rafi Cohen and Joshua Robin will be onboard the advisory panel to support the construction of the cultivation and processing project of Kayak in Israel. Craig said the company is excited to work with DTL on mutually beneficial projects. Kayak will benefit from product development and relationships in the scientific cannabis community of Israel.
Long time opportunity
Co-founder of GKC, Panos Kinnis, said their innovative ideas, approach, and vision helped expedite the launch of its products. It also offered a myriad of opportunities to cultivate growth. EU presents a long time demand for cannabidiol and medical cannabis products. GKC plans to go ahead with KBI to take an early lead and capitalize on the emerging opportunities to derive rich dividends.
The Greek government granted a cannabis installation license to GKC to commence Medical Cannabis Cultivation/ processing facility in Thebes, Greece. It will annually produce 225,000 pounds of medical cannabis products. Kayak established KBI to address global markets, leveraging its operational expertise.
https://mmjreporter.com/kaya-brands-international-inc-a-subsidiary-of-kaya-holdings-inc-otcmktskays-and-greekkannabis-will-introduce-cbd-pet-products-under-cannamo-brand-41046
Kaya Holdings, Inc. Enters into Strategic Partnership with
U.S.-Israeli Cannabis
Innovation Lab
Ft. Lauderdale, Fl., July 21 2020 - Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB.KAYS), the first U.S. publicly traded company to vertically integrate cannabis retail, cultivation and processing, announced today that it has formed a strategic partnership with Day Three Labs (“DTL”), a cannabis innovation and development lab headquartered in Denver, CO with scientific research operations in Ra’anana, outside of Tel Aviv, Israel.
Headquartered in Denver with research operations in Israel, DTL
taps into over 50 years of cannabinoid science research
to disrupt the cannabis industry by delivering Israeli innovation and
ingenuity to North America.
The parties will focus their first cooperative endeavor on sourcing and developing select CBD supplements for pets, to be distributed in Europe by Kaya Kannabis, KAYS’ joint venture in Greece. Additionally, both Joshua Rubin and Rafi Cohen, DTL’s principals, will serve on the Advisory Board of Kaya Shalvah, KAYS’ cultivation and processing project targeted for construction in Israel.
“We are extremely happy to be working closely with DTL on projects of mutual interest. Our association with them brings to KAYS distinctive Israeli product development, relationships in the Israeli cannabis scientific community, and the benefit of their experience and service,” stated KAYS CEO Craig Frank. “More importantly”, continued Frank, “this relationship demonstrates our commitment to the Kaya Shalvah project in Israel and our ability to operate cooperatively with those in the Israeli cannabis sector”.
According to DTL’s CEO, Joshua Rubin, “Our partnership with KAYS, a proven trailblazer and pioneer, furthers our efforts to drive innovation throughout the global cannabis industry. We are excited to collaborate on introducing exciting and differentiated cannabis products to the market, beginning with CBD pet supplements, and look forward to lending our cannabis expertise to KAYS advisory board.”
About Day Three Labs (https://daythreelabs.com)
Led by a team of CPG brand strategists and Israeli scientists, Day Three Labs (DTL) is a cannabinoid product innovation and development lab specializing in custom cannabis solutions. With headquarters in Denver and research operations in Israel, DTL taps into over 50 years of science research and plant study to disrupt the cannabis industry by delivering Israeli innovation and ingenuity to global markets. Product development spans a diverse range of the CPG space, including: health + wellness; skinceuticals; food + beverage; sports training + recovery; personal care; pet care; intimacy products; cosmetics; and women’s and men’s health. DTL helps brands tell a compelling narrative by designing differentiated products and, coupled with impact studies, illustrates CPG cannabinoid products perform as intended.
*****************************************************
Kaya Holdings files periodic reports with the U.S. Securities and Exchange Commission (the “SEC”). A copy of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, complete with pictures, store information and product testing, as well as our other periodic reports filed with the SEC, is available online at www.sec.gov or at www.otcmarkets.com.
To be advised of all upcoming News Releases and shareholder emails please go to www.kayaholdings.com and add your email to our notification list.
Also, please follow this link to see a video of how we are operating with our Covid-19 inspired safety enhancements to serve our medical and recreational marijuana customers via instore sales, curbside pickup and free delivery:
https://www.youtube.com/watch?v=-6TpVuFzxM8
****************************************************
About Kaya Holdings, Inc.- (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the counter market under the symbol OTCQB:KAYS.
KAYS Cannabis operations are conducted under three main majority-owned subsidiaries as further detailed below:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States.
Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories.
Kaya Brands International, Inc., was founded to serve as the vehicle for the Company’s non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
Marijuana Holdings Americas, Inc.-
U.S. Cannabis Operations
Kaya Shack™ Retail Cannabis Stores
In 2014, KAYS became the first United States publicly traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates three Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon.
Kaya Farms™
Eugene, Oregon Indoor Grow, Processing & Cannaceutical Facility: KAYS has developed its own proprietary Kaya Farms™ strains of cannabis, which it grows and produces (together with edibles and other cannabis derivatives) at its 12,000 square foot indoor grow and cannabis manufacturing facility in Eugene, Oregon, capable of producing approximately 1,500 pounds of premium cannabis annually, with the capacity for expansion. The Company also plans to use the space for production of oils, concentrates, extracts, edibles, and cannaceuticals. KAYS is currently conducting limited operations at the facility pending approval transfer of the production and processing licenses to KAYS by the Oregon Liquor Control Commission (the "OLCC"), the Oregon state regulating agency which regulates legal cannabis production, processing and sale.
Lebanon, Oregon Farm & Greenhouse Facility: KAYS owns a 26-acre parcel in Lebanon, Linn County, Oregon which it intends to construct a 85,000-square foot Kaya Farms™ greenhouse cultivation and production facility. To date KAYS has received Linn County Zoning approvals and upon issuance of OLCC Licensing it will begin construction. The farm is intended for immediate development and provides the Company with a potential additional capacity of more than 100,000 pounds annually, to be expanded once export from Oregon to other U.S. States and foreign countries where cannabis use is legal is permitted. Kaya Farms™ operates in accordance with a Grow Operations manual, as well as manuals for compliance, employment matters and safety.
?
Kaya Brands USA, Inc.-
Brand and Product Development
The Company maintains a genetics library of over 30 strains of cannabis and owns a number of proprietary brands in traditional and innovative cannabis categories including Kaya Buddies™ pre-rolls, Really Happy Glass™ cannabis accessories, and Kaya Gear™, company related and cannabis centric fashion. These brands are currently available at Kaya Shack™ stores.
?
The Company has made advances in the development of its Kumba Extracts™, Syzygy Extracts™, Pakalolo Juice Company™ Soothe Topicals™, Tony Giggles Pleasure Foods™ (frozen infused Italian entrees), Uptown Shaman™ (cannaceuticals), and Kaya Yums™ (chocolates, gummies, power bars) brands. and Kaya Yums™ brands of extracts, oils, vape cartridges, beverages and a variety of edibles, respectively. Pending approval of our production and processing license, KAYS intends to begin a multi-state rollout planned in 2020 to the extent permitted by U.S. legal infrastructure. These brands are intended for all Kaya Shack™ stores, both corporate owned and franchised.
Kaya Brands International, Inc.-
Foreign Cannabis Operations
After over five years of conducting "touch the plant" U.S. cannabis operations inside the strict regulatory confines of a public company, KAYS has formed a subsidiary, Kaya Brands International, Inc. ("KBI") to leverage its experience and expand into worldwide cannabis markets. KBI's current operations and initiatives include:
Canadian Franchising
KAYS has targeted Canada for its first international sale and operation of Kaya Shack™ cannabis store franchises. KAYS has entered into an area representation agreement with The Franchise Academy (a leading Canadian Franchise Development and Sales Group) to implement the Kaya Shack™Retail Cannabis Store program in Canada (the only G7 country that has legalized both medical and recreational cannabis production, sale and use on a national level). The agreement targets 75-100 Kaya Shack™ Cannabis Retail locations throughout Canada through a multi-year structured rollout, subject to licensing and market conditions.
The Franchise Academy (http://www.franchiseacademy.ca) and its founder Shawn Saraga, is a member and national sponsor of the Canadian Franchise Association. With over 15 years of industry experience and having successfully closed over 700 franchise agreements and leases across Canada, the Franchise Academy has the knowledge, expertise, network and dedication to assist select franchisors enter the Canadian market.
Additionally, KAYS has retained Toronto, Canada based law firm of Garfinkle Biderman, LLP to prepare the Franchise Disclosure Documents and related items for the sale of Kaya Shack™ cannabis store franchises in Canada. We expect the franchise sale and placement effort throughout Canada to progress over the next 3-24 months. KAYS plans to ultimately expand its franchise operations to the U.S., as regulations and laws permit.
Kaya Kannabis- Kaya Farms™ Greece
KAYS has entered into a Memorandum of Understanding ("MOU") setting forth an agreement in principle for KBI to acquire a 50% ownership interest in Greekkannabis, PC ("GKC"). GKC is a recently formed Athens, Greece based cannabis company which has applied for and is awaiting issuance of a medical cannabis cultivation, processing and export license from the Greek government.
The MOU sets forth an agreement in principle, pursuant to which in consideration for KBI providing the necessary expertise related to cannabis cultivation, processing, brand development and other matters, KBI will have the right to acquire a 50% ownership interest in GKC by reimbursing GKC for 50% of its license application costs (with allowances for KBI's expenses as well). Consummation of the transaction contemplated by the MOU is subject to, among other customary conditions, satisfactory completion by KBI of its due diligence review of GKC, the drafting, execution and delivery of definitive transaction documentation and final license approval and issuance by the Greek government.
GKC plans to establish its cannabis cultivation and processing facility on land already identified outside of Athens. Project management envisages 3 stages of development, each comprised of 125,000 square feet of light-deprivation greenhouse cultivation. Each phase is expected to produce 93,600 pounds of premium medical cannabis, for an anticipated total project capacity of not less than 280,0000 pounds annually for distribution throughout Europe and other select markets.
KAYS and KBI are represented in Greece by the Athens based law firm of Dalakos Fassolis Theofanopoulos (https://dftlaw.gr/). The firm has developed a long-established and well-respected commercial legal practice and has developed a wide international network of correspondent relationships with overseas law offices throughout the world.
Important Disclosure: KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to marijuana. Potential investors and shareholders are cautioned that KAYS and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664
SOURCE: Kaya Holdings, Inc.
****************************************************
?
Sign up and watch your email for notifications after we confirm the date and time of the next KAYS webinar and conference call to take questions on KAYS operations and development plans. Interested parties are advised to go to www.kayaholdings.com and register for KAYS updates; a confirmation email and participation code will be sent out to all shareholders and interested parties as soon as the date is set.
A copy of the Company’s latest filings complete with pictures, store information and other data as filed with the SEC is available online at www.sec.gov
Investor Update:
To access KAYS News & SEC Filings, Level II Quotes, News sign up for notifications of
please go to www.kayaholdings.com
and add your email to our list
Unsubscribe
This message was sent to abracky@yahoo.com from info@kayaholdings.com
KAYA SHACK (OTCQB: KAYS)
Craig Frank
305 S. Andrews Ave Suite 209
Fort Lauderdale, FL 33301
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Healthcare
Kaya Holdings and Greekkannabis to launch Cannamo
Jul. 08, 2020 12:26 PM ETKaya Holdings, Inc. (KAYS)By: Khyathi Dalal, SA News Editor1 Comment
Kaya Holdings' (OTCQB:KAYS -16.0%) majority owned subsidiary Kaya Brands International along with its Greek joint venture partner Greekkannabis plan to launch the Cannamo brand of CBD pet products for immediate distribution across Greece and neighboring European countries.
The brand's development will be facilitated through KAYS' relationship with the Israel/Colorado based Day Three Labs, which assisted in Europe product sourcing.
"We anticipate that our CBD pet products line will provide a revenue stream while we construct our planned medical cannabis facility in Greece and familiarize the market with our brands in anticipation of the planned development and launch of our THC products," Greekkannabis co-founder Elias Kammenos commented.
https://seekingalpha.com/news/3589566-kaya-holdings-and-greekkannabis-to-launch-cannamo
CANNABIS-INFUSED EDIBLE PRODUCTS MARKET OUTLOOK: POISED FOR A STRONG 2020 | BHANG, CANNABIS ENERGY DRINK, CANOPY GROWTH, DIXIE BRANDS
CRAIG CANNABIS-INFUSED EDIBLE PRODUCTS MARKET ANALYSIS, CANNABIS-INFUSED EDIBLE PRODUCTS MARKET FORECAST, CANNABIS-INFUSED EDIBLE PRODUCTS MARKET GROWTH, CANNABIS-INFUSED EDIBLE PRODUCTS MARKET OPPORTUNITY, CANNABIS-INFUSED EDIBLE PRODUCTS MARKET SHARE, CANNABIS-INFUSED EDIBLE PRODUCTS MARKET SIZE,CANNABIS-INFUSED EDIBLE PRODUCTS MARKET TRENDS,CANNABIS-INFUSED EDIBLE PRODUCTS UNITED STATES MARKET
Latest released the research study on Global Cannabis-infused Edible Products Market, offers a detailed overview of the factors influencing the global business scope. Cannabis-infused Edible Products Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Cannabis-infused Edible Products The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Baked Bros (United States), Bhang Corporation (United States), Cannabis Energy Drink (Netherlands), Canopy Growth Corporation (Canada), Dixie Brands Inc (United States), HEINEKEN Company (Netherlands), KANEH CO (United States), KIVA CONFECTIONS (United States), Kaya Holdings, Inc. (United States), Koios Beverage Corp. (Canada), LOL Edibles (United States) and Lord Jones (United States)
Free Sample Report + All Related Graphs & Charts @:https://www.advancemarketanalytics.com/sample-report/15953-global-cannabis-infused-edible-products-market
Over the past couple of decades, cannabis and cannabis-based products are being legalized in various geographic locations such as the United States. This has led to upsurge the social acceptance of cannabis products. Since cannabis products which are used for smoking have many side effects thus the demand for edibles manufactured from the cannabis has been escalated. Cannabis infused edible products which are also known as cannabis edibles comprise of liquid edible or a drinkable. It contains cannabinoid compounds such as cannabidiol (CBD) and tetrahydrocannabinol (THC). However, due to lack of awareness in the underdeveloped region might hinder business growth.
The Global Cannabis-infused Edible Products Market segments and Market Data Break Down are illuminated below:
by Type (Baked Products, Chocolates & Bars, Drinks, Gum & Sprays, Sugar Candies), Raw Material (Hemp CBD Oil, Marijuana CBD Oil), Distribution (Offline Mode, Online Mode), Source (Inorganic, Organic)
Analyst at AMA have conducted special survey and have connected with opinion leaders and Industry experts from various region to minutely understand impact on growth as well as local reforms to fight the situation. A special chapter in the study presents Impact Analysis of COVID-19 on Cannabis-infused Edible Products Market along with tables and graphs related to various country and segments showcasing impact on growth trends.
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Enquire for customization in Report @:https://www.advancemarketanalytics.com/enquiry-before-buy/15953-global-cannabis-infused-edible-products-market
Strategic Points Covered in Table of Content of Global Cannabis-infused Edible Products Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Cannabis-infused Edible Products market
Chapter 2: Exclusive Summary – the basic information of the Cannabis-infused Edible Products Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Cannabis-infused Edible Products
Chapter 4: Presenting the Cannabis-infused Edible Products Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying market size by Type, End User and Region 2014-2019
Chapter 6: Evaluating the leading manufacturers of the Cannabis-infused Edible Products market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2020-2025).
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
Finally, Cannabis-infused Edible Products Market is a valuable source of guidance for individuals and companies in decision framework.
Data Sources & Methodology
The primary sources involves the industry experts from the Global Cannabis-infused Edible Products Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.
In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company’s Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.
For Early Buyers | Get Up to 20% Discount on This Premium Report:https://www.advancemarketanalytics.com/request-discount/15953-global-cannabis-infused-edible-products-market
What benefits does AMA research study is going to provide?
Latest industry influencing trends and development scenario
CANNABIS INFUSED EDIBLES MARKET SIZE AND SHARE OVERVIEW 2027, MAJOR COMPANIES- KANEH CO, KAYA HOLDINGS, INC., BHANG CORPORATION, VCC BRANDS, ETC.
MAY 29, 2020 ANITA@ORBISRESEARCH.COM
Global Cannabis infused Edibles Market 2020 is an extensive, professional analysis delivering market research data which will be relevant for new market entrants or recognized players. The Cannabis infused Edibles study covers significant data that makes the record a convenient source for analysts, managers, Cannabis infused Edibles industry experts as well as other vital people get ready-to-access along with self-analyzed study together side tables and graphs to help market trends, drivers and economic struggles. Mixing the Cannabis infused Edibles information integration and analysis capacities with the findings that are applicable, this report also has predicted a robust future rise of this international Cannabis infused Edibles market in every its geographic and product sections. What is more, the Cannabis infused Edibles industry growth trends and marketing stations have been examined. The business investigation also has been done to explore the effect of various facets and understand that the total beauty of this business.
Request for a sample report herehttps://www.orbisresearch.com/contacts/request-sample/4691827
The analysis begins with market review and proceeds on increased prospects of this Cannabis infused Edibles market. A thorough segmentation investigation of this Cannabis infused Edibles market from the report. The analysis additionally covers upstream, equipment, downstream client survey, promotion stations, industry improvement tendency, and suggestions, firm summary, revenue share, and SWOT analysis of their top players from the Cannabis infused Edibles market are offered in the report.
Geographically, Cannabis infused Edibles report record is split into several vital Areas, together with production, consumption, revenue (Mn/Bn USD), along with market share and increase pace of Cannabis infused Edibles in those regions, by 2015 to 2027, covering North America, Europe, Latin America, Middle East and Africa, Asia-Pacific, and Rest of the world and also it’s Share (percent) and also CAGR for its forecast 2020 into 2027.
Market players– Since it’s crucial to expel market players, we’ve comprised a set of the market players, for example, their company profiles, profitability, and gross profit margin.
KANEH CO
Kaya Holdings, Inc.
Bhang Corporation
VCC BRANDS
HempFoods
NightFood Holdings, Inc.
Medically Correct, LLC.
KIVA CONFECTIONS
Organigram Holdings Inc.
Heineken
Baked Bros
Mentor Capital, Inc.
Lord Jones
Cannabis Energy Drink
Koios Beverage Corp.
Dixie
LOL Edibles
Plus Products
Canopy Growth Corp
Types– The particulars of the product is vital in the market; therefore, we’ve already categorized all of the specifics of the merchandise. Here’s a listing of the classes for Cannabis infused Edibles markets:
Food
Beverage
Others
Cannabis infused Edibles Application Utilization: The information about the user application is very essential, and people also endure knowledge within our market research document.
Pharmacy
Supermarkets and Hypermarkets
Online shopping mall
Others
You will find 15 Chapters to exhibit information of World Wide Cannabis infused Edibles marketplace:
Chapter 1, Definition, Specifications and Form of Cannabis infused Edibles, Software of Cannabis infused Edibles, Market Segment from Regions;
Chapter 2, Manufacturing Cost Structure, Raw-material and Providers, Manufacturing Processes, Industry Chain Structure;
Chapter 3, Specialized Information and Assembling Plants Examination of Cannabis infused Edibles, Limit and Business Generation Date, Assembling Appropriation, Research, and development Status and Innovation Source, Materials Sources;
Chapter 4, Entire Market Analysis, Capacity Analysis (Company Segment), Revenue Evaluation (Company Segment), Sales Price Analysis (Company Segment);
Chapter 5 and 6, Provincial Market Examination that incorporates North America, Europe, Latin America, Middle East and Africa, Asia-Pacific, and Rest of the world;
Chapter 7 and 8, The Cannabis infused Edibles Fragment Market (by Application) Producers Examination;
Chapter 9, Market Pattern Investigation, Provincial Market Pattern, Market Pattern by Type, Market Pattern by Application;
Chapter 10, Provincial Promoting Write Investigation, Global Exchange Compose Examination, Inventory network Examination;
Chapter 11, The Consumers Analysis of International Cannabis infused Edibles;
Chapter 12, Cannabis infused Edibles Exploration Discoveries and Conclusion, Index, strategy and information source;
Chapter 13, 14 and 15, Cannabis infused Edibles earnings channels, vendors, traders, traders, Research Findings and Decision, appendix and data origin.
Ask our Expert if You Have a Query at: https://www.orbisresearch.com/contacts/enquiry-before-buying/4691827
This is just a set of the possible questions which are answered within our market research document:
Q. Which would be the factors impacting the increasing pace of Cannabis infused Edibles market?
Q. Which will be the restraints which will sabotage increasing speed?
Q. Which would be the most top geographical places in Cannabis infused Edibles Market 2020-2027?
Q. Which will be the niches at which organizations profiling with thorough plans, financial, and also recent advancements should set a presence?
Q. What would be the challenges faced in Cannabis infused Edibles markets?
Q. What’s Cannabis infused Edibles market share, increase, earnings, sales, etc.?
Q. Which will be the application and types accompanied closely by players?
Q. What’s the reach of this Cannabis infused Edibles market?
Q. Cannabis infused Edibles market opportunities?
Q. Just how share fluctuations their worth from different Manufacturing brands?
To conclude, it’s an in-depth research report on Worldwide Cannabis infused Edibles market. The manufacturing cost of merchandise along with the arrangement embraced by the current Cannabis infused Edibles sector can be assessed in the accounts. Other Cannabis infused Edibles variables essential to discovering trends in the market like ingestion demand and distribution statistics and cost of production, gross income, and services can also be contained within the ambit of this document. The Cannabis infused Edibles report is around made out of a mixture of this simple advice relying upon the critical data of this global market, for example, an essential purpose accountable for fluctuation popular with services.
We say our thanks for its aid and support from Cannabis infused Edibles industry chains related specialized specialists and Advertising specialists during Research Team’s poll and interviews.
What’s looking good?
Looking good KAYS
Congrats on Your KAYS Sticky!!
Up 32% Today:
https://finance.yahoo.com/quote/KAYS?p=KAYS
Just got in on the news....hope it's not a P/D
OTCQB:KAYS NEWS ALERT
International Cannabis Company Kaya Holdings, Inc. Files 2019 Annual Report on Form 10-K Detailing Launch of Kaya Brands International and Issuance of Greek Cannabis License, COVID-19 Operational Response Report and 2019 Results of Operations
FORT LAUDERDALE, Fla., May 20, 2020 -- Kaya Holdings, Inc. (OTCQB:KAYS), announced that it has released fiscal year 2019 results of operations by filing its Annual Report on Form 10-K for the year ended December 31, 2019 with the SEC.
KAYS 2019 10-K highlights include the following updates:
Launch of Kaya Brands International, Inc.
As the first “touch the plant” U.S. cannabis company to operate inside the strict regulatory confines of a public company and after six (6) years of operations in Oregon, perhaps the most competitive cannabis market in the United States, KAYS has formed Kaya Brands International, Inc. (“KBI”), to serve as the vehicle from which KAYS will leverage its operational experience and expand operations into select and targeted global markets.
KBI Dividend/Spin-off Strategy: KAYS intends to maintain a majority ownership of KBI, but is also considering, in conjunction with its advisors, various strategies by which KBI can enhance its value to KAYS shareholders. Potential strategies under consideration include a dividend of a portion of KBI’s common stock to KAYS shareholders or otherwise spinning off KBI as a separately trading public company. There can be no assurance given as to whether or when KAYS will deterimine to implement a specific strategy, if ever, and to successfully implement any strategy selected.
Greek Cannabis License Issuance: KBI’s first EU Project is a joint venture cultivation-for-export cannabis project with Athens based Greekkannabis PC (“GKC”). GKC was recently issued its Cannabis Installation License by the Greek Government, permitting the commencement of construction of a planned 470,000 square foot Medical Cannabis Cultivation and Processing Facility on 15 acres of land in Thebes, Greece. The Company estimates total farm production, once completely constructed and operating at full capacity, to be at a minimum of approximately 225,000 pounds of medical cannabis annually, which is targeted for export to the European Union and other select markets.
Greenegev, Israeli Medical Cannabis Project: KBI has been invited to participate in Greenegev, the first cannabinoid ecosystem, which is currently under development in Yerucham, Israel. KBI is currently evaluating a potential site for construction of a medical cannabis production facility which would be designed to leverage Israel’s depth of cannabis research and advanced agricultural practices. Greenegev is intended to bethe equivalent of a “Silicon Valley” for medical cannabis being developed with the full support of the Israeli Government – including grants, licensing assistance and public/private initiatives. Moreover, the Israeli government has recently approved the growth and production of medical cannabis for export. Private sector partcipants in Greengev include companies such as Perrigo, a NYSE traded Irish pharmaceutical company which recently began expanding into the cannabis and CBD sectors.
For more information on our Greek and Israeli projects,
please access this link:
https://www.dropbox.com/sh/7dxarx89uxrjvkq/AABnkR1ou6uAr4Be0ehZCPn5a?dl=0
“We have spent the past 24 months developing the opportunities that will we believe that will allow KAYS to take advantage of potential foreign expansion opportunities, without waiting for development of domestic regulatory cohesion, which has inhibited growth for companies in U.S. cannabis industry, despite their ceployment of significant capital resources. commented KAYS CEO Craig Frank. “Rather we have expended comparatively less capital resources to secure in-depth operational experience that we anticipate can now be leveraged in environments more welcoming to an emerging cannabis industry. Both Greece and Israel have demonstrated the willingness to becomeglobal centers of cannabis excellence and we believe that KAYS, through KBI, has the opportunity to become be a visible and leading player in the primary and lucrative cannabis markets now emerging. As we see the so-called industry leaders pulling back from their massive acquisition and “lead by size” strategies where hundreds of millions of dollars were wasted, we believe the more considered and paced strategy we have always embraced – gain knowledge, gain experience, then execute – will now prevail as the more reasoned and ultimately more successful model.”
COVID-19 Operational Response
All of our Kaya Shack™ retail cannabis stores and Kaya Farms production facilities in Oregon continue to be fully operational and the Company is working closely with local and state authorities to ensure it is following or exceeding the stated guidelines related to COVID-19.
Please follow this link to see a video of how we are operating with our Covid-19 inspired safety enhancements to protect our employees and serve our Kaya Shack medical and recreational marijuana customers via in-store sales, curbside pickup and delivery from our signature Kaya Delivery Vehicles:
https://www.youtube.com/watch?v=-6TpVuFzxM8
2019 Results by the Numbers.
Revenues- We had revenues of $1,014,266 for the year ended December 31, 2019, as compared to revenues of $1,136,599 for the year ended December 31, 2018, a decrease of 10% due to the closing of a non-performing store as we looked to reduce expenses and consolidate operations as we transition to international operations.
Operating Expenses- Total operating expenses were $2,264,883 for the year ended December 31, 2019, as compared to $2,870,627 for the year ended December 31, 2018 as we were able to reduce our salaries and professional Fees significantly.
Debt Restructuring- At December 31, 2019 we had approximately $7.2 million in convertible debt due between January 1, 2020 and 2022 which we had accumulated over the past six years to finance the development of our cannabis operations and our public company overhead. We are pleased to confirm that as of January 1, 2020 we have refinanced approximately $6.8 million of this debt so that no interest and principal payments are due until January 1, 2024 and we are in the process of negotiating with the remaining debt holders to further reduce those obligations as well so that we may concentrate on utilizing funds raised through future securities offering to pay down some accumulated professional fees and operational expenses and target the balance for expansion and building the Company as we move forward.
A copy of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, complete with pictures, store information and product testing as filed with the SEC, is available online at www.sec.gov or at www.otcmarkets.com.
Note: To be advised of all upcoming News Releases and shareholder emails please go to www.kayaholdings.com and add your email to our notification list.
Note: As the focus of our business model has migrated towards the Global Cannabis Markets, our press releases are now distributed to several countries including the United States, Canada, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Luxemburg, Netherlands, Norway, Portugal, Scotland, Spain, Sweden, Switzerland, Turkey, UK & Ireland, with full translations available in English, German, French and Spanish. Depending on the nature of the release we may also add additional circuits and translations in other languages.
****************************************************
About Kaya Holdings, Inc.- (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the counter market under the symbol OTCQB:KAYS.
KAYS Cannabis operations are conducted under three main majority-owned subsidiaries as further detailed below:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States.
Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories.
Kaya Brands International, Inc., was founded to serve as the vehicle for the Company’s non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
Marijuana Holdings Americas, Inc.-
U.S. Cannabis Operations
Kaya Shack™ Retail Cannabis Stores
In 2014, KAYS became the first United States publicly traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates two Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon, and is in the process of relocating a third retail cannabis license to serve as a delivery hub for the Eugene and Southern Oregon Cannabis Market.
Kaya Farms™
Eugene, Oregon Indoor Grow, Processing & Cannaceutical Facility: KAYS has developed its own proprietary Kaya Farms™ strains of cannabis, which it grows and produces (together with edibles and other cannabis derivatives) at its 12,000 square foot indoor grow and cannabis manufacturing facility in Eugene, Oregon, capable of producing approximately 1,500 pounds of premium cannabis annually, with the capacity for expansion. The Company also plans to use the space for production of oils, concentrates, extracts, edibles, and cannaceuticals. KAYS is currently conducting limited operations at the facility pending approval transfer of the production and processing licenses to KAYS by the Oregon Liquor Control Commission (the "OLCC"), the Oregon state regulating agency which regulates legal cannabis production, processing and sale.
Lebanon, Oregon Farm & Greenhouse Facility: KAYS owns a 26-acre parcel in Lebanon, Linn County, Oregon which it intends to construct a 85,000-square foot Kaya Farms™ greenhouse cultivation and production facility. To date KAYS has received Linn County Zoning approvals and upon issuance of OLCC Licensing it will begin construction. The farm is intended for immediate development and provides the Company with a potential additional capacity of more than 100,000 pounds annually, to be expanded once export from Oregon to other U.S. States and foreign countries where cannabis use is legal is permitted. Kaya Farms™ operates in accordance with a Grow Operations manual, as well as manuals for compliance, employment matters and safety.
?
Kaya Brands USA, Inc.-
Brand and Product Development
The Company maintains a genetics library of over 30 strains of cannabis and owns a number of proprietary brands in traditional and innovative cannabis categories including Kaya Buddies™ pre-rolls, Really Happy Glass™ cannabis accessories, and Kaya Gear™, company related and cannabis centric fashion. These brands are currently available at Kaya Shack™ stores.
?
The Company has made advances in the development of its Kumba Extracts™, Syzygy Extracts™, Pakalolo Juice Company™ Soothe Topicals™, Tony Giggles Pleasure Foods™ (frozen infused Italian entrees), Uptown Shaman™ (cannaceuticals), and Kaya Yums™ (chocolates, gummies, power bars) brands. and Kaya Yums™ brands of extracts, oils, vape cartridges, beverages and a variety of edibles, respectively. Pending approval of our production and processing license, KAYS intends to begin a multi-state rollout planned in 2020 to the extent permitted by U.S. legal infrastructure. These brands are intended for all Kaya Shack™ stores, both corporate owned and franchised.
Kaya Brands International, Inc.-
Foreign Cannabis Operations
After nearly six years of conducting "touch the plant" U.S. cannabis operations inside the strict regulatory confines of a public company, KAYS has formed a subsidiary, Kaya Brands International, Inc. ("KBI") to leverage its experience and expand into worldwide cannabis markets. KBI's current operations and initiatives include:
Canadian Franchising
KAYS has targeted Canada for its first international sale and operation of Kaya Shack™ cannabis store franchises. KAYS has entered into an area representation agreement with The Franchise Academy (a leading Canadian Franchise Development and Sales Group) to implement the Kaya Shack™Retail Cannabis Store program in Canada (the only G7 country that has legalized both medical and recreational cannabis production, sale and use on a national level). The agreement targets 75-100 Kaya Shack™ Cannabis Retail locations throughout Canada through a multi-year structured rollout, subject to licensing and market conditions.
The Franchise Academy (http://www.franchiseacademy.ca) and its founder Shawn Saraga, is a member and national sponsor of the Canadian Franchise Association. With over 15 years of industry experience and having successfully closed over 700 franchise agreements and leases across Canada, the Franchise Academy has the knowledge, expertise, network and dedication to assist select franchisors enter the Canadian market.
Additionally, KAYS has retained Toronto, Canada based law firm of Garfinkle Biderman, LLP to prepare the Franchise Disclosure Documents and related items for the sale of Kaya Shack™ cannabis store franchises in Canada. We expect the franchise sale and placement effort throughout Canada to progress over the next 3-24 months. KAYS plans to ultimately expand its franchise operations to the U.S., as regulations and laws permit.
Kaya Kannabis- Kaya Farms™ Greece
KAYS has entered into a Memorandum of Understanding ("MOU") setting forth an agreement in principle for KBI to acquire a 50% ownership interest in Greekkannabis, PC ("GKC"). GKC is a recently formed Athens, Greece based cannabis company which has applied for and is awaiting issuance of a medical cannabis cultivation, processing and export license from the Greek government.
The MOU sets forth an agreement in principle, pursuant to which in consideration for KBI providing the necessary expertise related to cannabis cultivation, processing, brand development and other matters, KBI will have the right to acquire a 50% ownership interest in GKC by reimbursing GKC for 50% of its license application costs (with allowances for KBI's expenses as well). Consummation of the transaction contemplated by the MOU is subject to, among other customary conditions, satisfactory completion by KBI of its due diligence review of GKC, the drafting, execution and delivery of definitive transaction documentation and final license approval and issuance by the Greek government.
GKC plans to establish its cannabis cultivation and processing facility on land already identified outside of Athens. Project management envisages a total of 425,000 square feet of light deprivation greenhouses situated on fifteen acres of land, and supported by an additional 50,000 sq. feet building for workspace, storage and administrative offices. The Company estimates total farm production, once completely constructed and operating at full capacity, to be at a minimum of approximately 225,000 pounds of premium grade cannabis annually.
Licensing Status: On April 22, 2020 KAYS/KBI received confirmation from their Greek Counsel that the Greek Government had awarded the crucial Installation License for the project.
KAYS and KBI are represented in Greece by the Athens based law firm of Dalakos Fassolis Theofanopoulos (https://dftlaw.gr/). The firm has developed a long-established and well-respected commercial legal practice and has developed a wide international network of correspondent relationships with overseas law offices throughout the world.
Important Disclosure: KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to marijuana. Potential investors and shareholders are cautioned that KAYS and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664
SOURCE: Kaya Holdings, Inc.
****************************************************
?
Sign up and watch your email for notifications after we confirm the date and time of the next KAYS webinar and conference call to take questions on KAYS operations and development plans. Interested parties are advised to go to www.kayaholdings.com and register for KAYS updates; a confirmation email and participation code will be sent out to all shareholders and interested parties as soon as the date is set.
A copy of the Company’s latest filings complete with pictures, store information and other data as filed with the SEC is available online at www.sec.gov
Investor Update:
To access KAYS News & SEC Filings, Level II Quotes, News sign up for notifications of
please go to www.kayaholdings.com
and add your email to our list
Unsubscribe
This message was sent to abracky@yahoo.com from info@kayaholdings.com
KAYA SHACK (OTCQB: KAYS)
Craig Frank
305 S. Andrews Ave Suite 209
Fort Lauderdale, FL 33301
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Potential reversal. Sector heating up
Got My Hopes up for KAYS.......but when ....I do not know?
OTCQB:KAYS NEWS ALERT
International Cannabis Company Kaya Holdings, Inc. (OTCQB:KAYS) Files 10-K Detailing Recently Issued Greek Medical Cannabis Installation License, 2019 Results of Operations and Debt Restructuring in Preparation of 506 C Offering
From the desk of Craig Frank:
Please be advised that our 2019 Annual Report on Form 10-K was filed Wednesday afternoon just after the market close.
We will be issuing a summary release detailing and discussing the filing early next week and confirming details of a Zoom Video conference call scheduled over the next month to discuss the status of Kaya Brands International and the projects we are involved in including the recently issued Greek Medical Cannabis Installation License, but wanted to make sure our shareholders and investors knew that the report is now available at either sec.gov or otcmarkets.com for review.
Note: As the focus of our business model has migrated towards the Global Cannabis Markets, our press releases are now distributed to several countries including the United States, Canada, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Luxemburg, Netherlands, Norway, Portugal, Scotland, Spain, Sweden, Switzerland, Turkey, UK & Ireland, with full translations available in English, German, French and Spanish. Depending on the nature of the release we may also add additional circuits and translations in other languages.
Also, please follow this link to see a video of how we are operating with our Covid-19 inspired safety enhancements to serve our medical and recreational marijuana customers via instore sales, curbside pickup and free delivery:
https://www.youtube.com/watch?v=-6TpVuFzxM8
Thank you and stay safe.
Kaya Holdings and Kaya Brands International
Craig Frank, CEO and Chairman
****************************************************
About Kaya Holdings, Inc.- (www.kayaholdings.com)
Kaya Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated legal cannabis company operating a number of majority owned subsidiaries that retail, cultivate, produce and distribute premium medical and recreational cannabis products, including flower, concentrates, oils and extracts, cannabis-infused foods and beverages, topicals and cannaceuticals. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB Tier of the over-the counter market under the symbol OTCQB:KAYS.
KAYS Cannabis operations are conducted under three main majority-owned subsidiaries as further detailed below:
Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations that operate in the United States.
Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, food and beverages, cannaceuticals and related accessories.
Kaya Brands International, Inc., was founded to serve as the vehicle for the Company’s non-U.S. operations including retail franchising in Canada and cultivation activities in Greece and Israel.
Marijuana Holdings Americas, Inc.-
U.S. Cannabis Operations
Kaya Shack™ Retail Cannabis Stores
In 2014, KAYS became the first United States publicly traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates three Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon.
Kaya Farms™
Eugene, Oregon Indoor Grow, Processing & Cannaceutical Facility: KAYS has developed its own proprietary Kaya Farms™ strains of cannabis, which it grows and produces (together with edibles and other cannabis derivatives) at its 12,000 square foot indoor grow and cannabis manufacturing facility in Eugene, Oregon, capable of producing approximately 1,500 pounds of premium cannabis annually, with the capacity for expansion. The Company also plans to use the space for production of oils, concentrates, extracts, edibles, and cannaceuticals. KAYS is currently conducting limited operations at the facility pending approval transfer of the production and processing licenses to KAYS by the Oregon Liquor Control Commission (the "OLCC"), the Oregon state regulating agency which regulates legal cannabis production, processing and sale.
Lebanon, Oregon Farm & Greenhouse Facility: KAYS owns a 26-acre parcel in Lebanon, Linn County, Oregon which it intends to construct a 85,000-square foot Kaya Farms™ greenhouse cultivation and production facility. To date KAYS has received Linn County Zoning approvals and upon issuance of OLCC Licensing it will begin construction. The farm is intended for immediate development and provides the Company with a potential additional capacity of more than 100,000 pounds annually, to be expanded once export from Oregon to other U.S. States and foreign countries where cannabis use is legal is permitted. Kaya Farms™ operates in accordance with a Grow Operations manual, as well as manuals for compliance, employment matters and safety.
?
Kaya Brands USA, Inc.-
Brand and Product Development
The Company maintains a genetics library of over 30 strains of cannabis and owns a number of proprietary brands in traditional and innovative cannabis categories including Kaya Buddies™ pre-rolls, Really Happy Glass™ cannabis accessories, and Kaya Gear™, company related and cannabis centric fashion. These brands are currently available at Kaya Shack™ stores.
?
The Company has made advances in the development of its Kumba Extracts™, Syzygy Extracts™, Pakalolo Juice Company™ Soothe Topicals™, Tony Giggles Pleasure Foods™ (frozen infused Italian entrees), Uptown Shaman™ (cannaceuticals), and Kaya Yums™ (chocolates, gummies, power bars) brands. and Kaya Yums™ brands of extracts, oils, vape cartridges, beverages and a variety of edibles, respectively. Pending approval of our production and processing license, KAYS intends to begin a multi-state rollout planned in 2020 to the extent permitted by U.S. legal infrastructure. These brands are intended for all Kaya Shack™ stores, both corporate owned and franchised.
Kaya Brands International, Inc.-
Foreign Cannabis Operations
After over five years of conducting "touch the plant" U.S. cannabis operations inside the strict regulatory confines of a public company, KAYS has formed a subsidiary, Kaya Brands International, Inc. ("KBI") to leverage its experience and expand into worldwide cannabis markets. KBI's current operations and initiatives include:
Canadian Franchising
KAYS has targeted Canada for its first international sale and operation of Kaya Shack™ cannabis store franchises. KAYS has entered into an area representation agreement with The Franchise Academy (a leading Canadian Franchise Development and Sales Group) to implement the Kaya Shack™Retail Cannabis Store program in Canada (the only G7 country that has legalized both medical and recreational cannabis production, sale and use on a national level). The agreement targets 75-100 Kaya Shack™ Cannabis Retail locations throughout Canada through a multi-year structured rollout, subject to licensing and market conditions.
The Franchise Academy (http://www.franchiseacademy.ca) and its founder Shawn Saraga, is a member and national sponsor of the Canadian Franchise Association. With over 15 years of industry experience and having successfully closed over 700 franchise agreements and leases across Canada, the Franchise Academy has the knowledge, expertise, network and dedication to assist select franchisors enter the Canadian market.
Additionally, KAYS has retained Toronto, Canada based law firm of Garfinkle Biderman, LLP to prepare the Franchise Disclosure Documents and related items for the sale of Kaya Shack™ cannabis store franchises in Canada. We expect the franchise sale and placement effort throughout Canada to progress over the next 3-24 months. KAYS plans to ultimately expand its franchise operations to the U.S., as regulations and laws permit.
Kaya Kannabis- Kaya Farms™ Greece
KAYS has entered into a Memorandum of Understanding ("MOU") setting forth an agreement in principle for KBI to acquire a 50% ownership interest in Greekkannabis, PC ("GKC"). GKC is a recently formed Athens, Greece based cannabis company which has applied for and is awaiting issuance of a medical cannabis cultivation, processing and export license from the Greek government.
The MOU sets forth an agreement in principle, pursuant to which in consideration for KBI providing the necessary expertise related to cannabis cultivation, processing, brand development and other matters, KBI will have the right to acquire a 50% ownership interest in GKC by reimbursing GKC for 50% of its license application costs (with allowances for KBI's expenses as well). Consummation of the transaction contemplated by the MOU is subject to, among other customary conditions, satisfactory completion by KBI of its due diligence review of GKC, the drafting, execution and delivery of definitive transaction documentation and final license approval and issuance by the Greek government.
GKC plans to establish its cannabis cultivation and processing facility on land already identified outside of Athens. Project management envisages 3 stages of development, each comprised of 125,000 square feet of light-deprivation greenhouse cultivation. Each phase is expected to produce 93,600 pounds of premium medical cannabis, for an anticipated total project capacity of not less than 280,0000 pounds annually for distribution throughout Europe and other select markets.
KAYS and KBI are represented in Greece by the Athens based law firm of Dalakos Fassolis Theofanopoulos (https://dftlaw.gr/). The firm has developed a long-established and well-respected commercial legal practice and has developed a wide international network of correspondent relationships with overseas law offices throughout the world.
Important Disclosure: KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to marijuana. Potential investors and shareholders are cautioned that KAYS and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664
SOURCE: Kaya Holdings, Inc.
****************************************************
?
Sign up and watch your email for notifications after we confirm the date and time of the next KAYS webinar and conference call to take questions on KAYS operations and development plans. Interested parties are advised to go to www.kayaholdings.com and register for KAYS updates; a confirmation email and participation code will be sent out to all shareholders and interested parties as soon as the date is set.
A copy of the Company’s latest filings complete with pictures, store information and other data as filed with the SEC is available online at www.sec.gov
Investor Update:
To access KAYS News & SEC Filings, Level II Quotes, News sign up for notifications of
please go to www.kayaholdings.com
and add your email to our list
KAYA SHACK (OTCQB: KAYS)
Craig Frank
305 S. Andrews Ave Suite 209
Fort Lauderdale, FL 33301
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
?
?
Looks like the Cannabis Market is at a Standstill at this Time!!
Cannabis-Infused Edibles Market 2020: Business Opportunities, Current Trends, Industry Challenges and Global Industry Analysis by 2024
BY QURATE BUSINESS INTELLIGENCE ON APRIL 13, 2020
The global cannabis-infused edibles market is expected to grow from USD 562.56 million 2017 to USD 3,292.68 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 28.71%.
Cannabis-Infused Edibles Market has recently added by Qurate Research to its vast repository. This intelligence report includes investigations based on Current scenarios, Historical records, and future predictions. An accurate data of various aspects such as Type, Size, Application, and end-user have been scrutinized in this research report. It presents the 360-degree overview of the competitive landscape of the industries. SWOTanalysis has been used to understand the Strength, Weaknesses, Opportunities, and threats in front of the businesses. Thus, helping the companies to understand the threats and challenges in front of the businesses. Cannabis-Infused Edibles Market is showing steady growth and CAGR is expected to improve during the forecast period.
The key players profiled in the global cannabis-infused edibles market are Baked Bros, Bhang Corporation, Cannabis Energy Drink, Canopy Growth Corp, Dixie, Heineken, KANEH CO, KIVA CONFECTIONS, Kaya Holdings, Inc., Koios Beverage Corp., LOL Edibles, Lord Jones, Medically Correct, LLC., Mentor Capital, Inc., NightFood Holdings, Inc., Organigram Holdings Inc., Plus Products, and VCC BRANDS.
On the basis of product, the global cannabis-infused edibles market is studied across Baked Products, Chocolates & Bars, Drinks, Gum & Sprays, and Sugar Candies.
On the basis of raw material, the global cannabis-infused edibles market is studied across Hemp CBD Oil and Marijuana CBD Oil.
On the basis of source, the global cannabis-infused edibles market is studied across Inorganic and Organic.
On the basis of distribution channel, the global cannabis-infused edibles market is studied across Offline Mode and Online Mode.
The Cannabis-Infused Edibles market report includes comprehensive information about the market’s major competitors, including various organizations, companies, associations, suppliers and manufacturers competing for production, supply, sales, revenue generation, and after-sales performance expectations. The bargaining power of numerous vendors and buyers have also been included in the research report.
A Free report data (as a form of Excel Datasheet) will also be provided upon request along with a new purchase.
Kaya Holdings Inc (Q (KAYS)
0.0269 0.0034 (14.47%)
Volume: 310,771 @04/09/20 3:17:28 PM EDT
So cheap down here! Very tempting to just clear out the 3’s!
WOW....Look at that Line.
Thanks...very impressive...thanks JJ24
up 62% Today.....KOOL!
Kaya could learn.
Reviewing ArQule (NASDAQ:ARQL) & Kaya (NASDAQ:KAYS)
Posted by Elizabeth Aliyeva on Mar 22nd, 2020
ArQule (NASDAQ:ARQL) and Kaya (OTCMKTS:KAYS) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.
Institutional & Insider Ownership
Get ArQule alerts:
74.6% of ArQule shares are owned by institutional investors. 13.8% of ArQule shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares ArQule and Kaya’s net margins, return on equity and return on assets.
Net MarginsReturn on EquityReturn on AssetsArQule-805.61%-33.10%-26.87%Kaya183.23%N/A-100.00%
Earnings & Valuation
This table compares ArQule and Kaya’s revenue, earnings per share and valuation.
Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArQule$25.76 million93.85-$15.48 million($0.16)-125.00Kaya$1.14 million3.04$4.75 millionN/AN/A
Kaya has lower revenue, but higher earnings than ArQule.
Volatility and Risk
ArQule has a beta of 2.49, indicating that its share price is 149% more volatile than the S&P 500. Comparatively, Kaya has a beta of -0.29, indicating that its share price is 129% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations for ArQule and Kaya, as reported by MarketBeat.
Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating ScoreArQule06302.33Kaya0000N/A
ArQule currently has a consensus price target of $17.50, suggesting a potential downside of 12.50%. Given ArQule’s higher possible upside, equities research analysts clearly believe ArQule is more favorable than Kaya.
Summary
ArQule beats Kaya on 8 of the 12 factors compared between the two stocks.
About ArQule
?ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. The company's pipeline includes ARQ 531, an orally bioavailable, potent and reversible dual inhibitor of wild type and C481S-mutant Bruton's tyrosine kinase that is in Phase I trial for patients with B-cell malignancies refractory to other therapeutic options; and miransertib (ARQ 092), a potent and selective inhibitor of the protein kinase B (AKT), a serine/threonine kinase, which is in Phase Ib in combination with the hormonal therapy and anastrozole in patients with advanced endometrial cancer. Its pipeline also comprises ARQ 75, a potent and selective inhibitor of AKT that is in Phase I clinical development for solid tumors harboring AKT, phosphoinositide 3-kinase or phosphatase, and tensin homolog loss mutations. In addition, the company's pipeline includes Derazantinib (ARQ 087), a multi-kinase inhibitor designed to preferentially inhibit the fibroblast growth factor receptor (FGFR) family of kinases that is in a registrational clinical trial in intrahepatic cholangiocarcinoma in patients with FGFR2 fusions. ArQule, Inc. has license agreements with Basilea Pharmaceutica Limited and Roivant Sciences Ltd. The company was founded in 1993 and is headquartered in Burlington, Massachusetts.
About Kaya
?Kaya Holdings, Inc., through its subsidiary, Marijuana Holdings Americas, Inc., engages in the legal recreational and medical marijuana business in the United States. The company is involved in growing, cultivation, harvesting, and manufacturing medical marijuana. It also operates four retail outlets for the sale of recreational and medical cannabis under the Kaya Shack brand name in Oregon, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.
Receive News & Ratings for ArQule Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ArQule and related companies with MarketBeat.com's FREE daily email newsletter.
Just checking in on everything at KAYS!
O/S has grown over the years. KAYS is or was growing their own weed. As far as filing, it's not unusual for them to file for extensions, but the do file. Annual and quarterly shouldn't come out until April. KAYS issuing of discounted shares is having its impact on PPS.
Yes.....That is why KAYS is not making a profit.
Too much competition.
Geographical Location is diluted with too Many Competitors.
Great Catch there.
Does KAYS report on time? I have not been watching much is the O/S growing? Its at 187M out of 500M. The whole sector has been under performing, very disappointing. Just Portland and 3 stores in Salem. Are they growing their own weed? How it going RSP If this is lagging because of Frank and not market conditions then that's sad. It just keeps dropping yet I have been to the Portland store I know an effort is being made. Have yourself a good one. GLTA Might try some Kaya buddies, see if its fresh.
Oregon has so much pot they are more than happy to have visitors buy all they want. I leave in Oregon City just outside of Portland. Pop. 25K 15 pot stores here. KAYS has a lot of competition were they are located. Hell probably 50 or 60 shops before I make it to Kaya.
Followers
|
169
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
14428
|
Created
|
08/26/11
|
Type
|
Free
|
Moderators |
Marijuana Holdings Americas (KAYS subsidiary)
Our Strategy
KAYS believes that as other states monitor the success of the Colorado and Washington experiments and witness the growing tax base from legal marijuana, wider acceptance of recreational marijuana will become the norm.
Our strategy is comprised of 5 components:
1. Seek licenses to cultivate, process and/or retail medicinal and/or recreational marijuana in accordance with local laws and regulations.
2. Begin license process in states with established legal marijuana markets as well as those implementing new laws.
3. Select states without legal marijuana that we believe will enact laws in the not-to-distant future and become active in the pro-legalization lobbying efforts.
4. Provide ancillary support in markets while awaiting licensing eligibility, including real estate (farm land, warehouses, and commercial sites).
5. Pursue viable and responsible acquisitions in the sector, leveraging the advantages of the company’s public status.
Markets
The legal marijuana market is estimated to grow more than 700% over the next five years, to more than $10 billion annually. The demand is expected to come both from growth within existing markets with legal marijuana (medicinal or recreational) and the additional of new markets as more states legalize marijuana for medicinal and/or recreational use.
Apr 7, 2015 AFAI'S Marijuana Operations Now 'Kaya Holdings,' New Trading Symbol (OTCQB:KAYS) Starts Today [Market News Publishing (US)] Feb 3, 2015 To Focus On Legal Marijuana Industry; Name And Symbol Change | ||
| |
Marijuana Holdings Americas, Inc.
KAYS Shareholder News
|
KAYS RECEIVES FIRST LICENSE FOR OREGON MEDICAL MARIJUANA FACILITY, CONFIRMS RECEIPT OF INITIAL FINANCING FOR MARIJUANA DISPENSARIES |
Hollywood, Florida: April 10, 2014 – KAYS announced today that its subsidiary Marijuana Holdings Americas, Inc. has been granted a provisional license to open a Medical Marijuana Facility (MMF) in Portland, Oregon. MJAI now has until May 20, 2014 to file its security and operational plans, upon which the State issues its certification so the MMF can begin lawful operations as MJAI’s first Medical Marijuana Dispensary.
“We are pleased that our application has been approved. We plan for this to be the first of many” states CEO Craig Frank. “We have secured our lease and our security system installation and operations manuals are on schedule. We are completing the site improvements and ordering all store fixtures. Our plan is to develop a powerful and appealing brand and provide a friendly and knowledgeable consumer experience, making our MMFs the first choice for all medical marijuana patients in Portland”.
This license marks the implementation of the Company’s business plan that calls for activity in the legal marijuana sector in select states. The Company has also targeted states with pending legislation, including its home state, Florida, where a referendum on medical marijuana is schedule to be on the ballot in November.
“We have our game plan and what we believe to be a well-conceived strategy which we are thoughtfully executing”, continues Mr. Frank, “This license is the fulfillment of our stated goal and demonstrates we have the will and the skill to execute”.
In a related matter, the Company announces that it received $250,000 of institutional funding in the first quarter of 2014. These funds will be earmarked for the Company’s subsidiary Marijuana Holdings Americas, Inc. The funding was an equity transaction and did not involve convertible debt.
Marijuana Holdings Americas (MJAI)
KAYS subsidiary, Marijuana Holdings Americas, Inc. was founded to enter the rapidly growing medical and recently legalized recreational marijuana market with the goal of securing new medical and recreational marijuana licenses, potentially acquiring existing Cannabis production/sales operations and evaluating related business opportunities, subject to legal compliance and advice of counsel.
IMPORTANT DISCLOSURE: KAYS and MJAI are planning execution of their stated business objectives in accordance with current understanding of State and Local Laws and Federal Enforcement Policies and Priorities as it relates to Marijuana (as outlined in the Justice Department's Cole Memo dated August 29, 2013), and plan to proceed cautiously with respect to legal and compliance issues. Potential investors and shareholders are cautioned that KAYS and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing Cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS and MJAI, Federal, State or Local legal action or changes in Federal Government Policy and/or State and Local Laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
1719 SE Hawthorne Boulevard, Portland, OR 97214
$KAYS DAILY CHART
$KAYS WEEKLY CHART
http://www.kayashack.com/
Welcome to Kaya Shack – the most positive MMF in Portland. We are open every day from 10:00 am to 10:00 pm to serve you.
At Kaya Shack you will always find a warm and friendly environment hosted by budmasters who deeply care about you and your needs. We strive to bring you the best medicines at a cost that permits you unburdened access.
We are here to serve you. We are pleased to serve you. Meeting your medical marijuana needs is important to us, because you are important to us.
Please explore our website. View our extensive menu as we are adding new items for you all the time, and view our specials as we always have some items discounted for you.
Most importantly, if you have any questions or comments please feel free to contact us. Your opinions and needs are important to us. We will listen and act as best we can to satisfy you.
Thanks for stopping by.
https://www.facebook.com/KayaShack
KAYA Customers Line Up Around the Block above for 4/20/15 Specials
Kaya Shack #2, our new Marijuana Superstore is in a major shopping center with a grand opening targeted to coincide with potential early rec sales in Oregon. With clean lines and an inviting atmosphere, our Kaya Shacks make good neighbors for both local and nationally recognized businesses such as Little Cesars, Subway, Walmart, National and many others.
Craig Frank, CEO of Kaya Holdings. “The first class space, with a footprint roughly three times the size of our first Kaya Shack™ MMD in Portland, was carefully chosen with an eye towards multiple usages to both enhance revenues and broaden branding opportunities.
Kaya Holdings Inc. Presentation (KAYS)
Cannabis Investor Webcast 4-9-2015
http://www.youtube.com/watch?v=boFD6svhYW4
KAYS GROW CAM LINK
https://video.nest.com/clip/c57a32050e6d4fc2a74d1928f8e7aed6.mp4
Ore. medical pot dispensaries prep for rec sales video featuring Kaya Shack
http://koin.com/2015/09/28/oregon-medical-pot-dispensaries-prep-for-rec-sales/
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |